CX united: Vascular world set to converge with challenging cases
The World Federation of Vascular Societies (WFVS) is bringing the vascular world together at CX 2024 to chew over both challenging cases and leadership...
Paclitaxel controversy: Yes, device restrictions did cause harm
“Unfortunately, we are doing worse for our patients today,” were the sobering thoughts of Eric Secemsky (Boston, United States) during a late-breaking presentation in...
SVS launches Vascular Board Certification Model Task Force
The Society for Vascular Surgery (SVS) Executive Board has established the Vascular Board Certification Model Task Force to deliver a final report entitled “Free-standing...
SVS announces candidates for 2024–25 vice president
The Society for Vascular Surgery (SVS) has announced Linda Harris, MD, and Palma Shaw, MD, as the candidates for the upcoming election for SVS...
Latest iteration of SVS program seeks to help foster development of resilient leaders
As the Society for Vascular Surgery (SVS) prepares to launch its fifth cohort of the Leadership Development Program (LDP), anticipation is high among aspiring...
Research provides ‘stepping stone’ for future application of AI in vascular surgery
New research on Chat generative pre-trained transformer (GPT) technology and its Vascular Education and Self-Assessment Program (VESAP) success rate provides insight into the future...
Physician-assembled unitary stent graft platform for debranched TAAA repair found safe and effective
Researchers behind a seven-year retrospective analysis of a physician-developed unitary stent graft system for endovascular debranched aortic repair of various thoracoabdominal aortopathies reported a...
How intersociety collaboration to promote private practice could help vascular surgery amid workforce crisis
Dawn M. Coleman, MD, chief of vascular surgery at the Duke University School of Medicine in Durham, North Carolina, focused on the likely major...
Bad reading: How to claw back negative revenue?
Five frequently performed vascular surgeries at a prominent New Orleans-based health system between 2019 and 2022 yielded an average yearly decrease in net revenue...
Study details link between increased functional status and improved survival in prosthesis-fitted amputees
Increasing functional status vascular patients fitted with a prosthesis after amputation was incrementally associated with improved survival, a retrospective analysis of a 10-year experience...
Greenhalgh legacy set to continue at CX 2024
Though the 2024 edition of the Charing Cross (CX) International Symposium (April 23–25) in London, England, marks a new era, it will be tinged...
The top 10 most popular Vascular Specialist stories of March 2024
In March, the most read stories from Vascular Specialist include a new analysis which suggests of a ‘lack of reach’ of vascular voices within...
FlowTriever device found to dramatically improve breathing among intermediate-risk acute pulmonary embolism patients
SCVS 2024 saw Zachary AbuRahma, DO, an assistant professor of vascular surgery at West Virginia University and the Charleston Area Medical Center in Charleston,...
Novel ultrasound-facilitated thrombectomy with microbubbles shows promise in acute porcine model for DVT treatment
Evaluation of the safety and performance of a novel pharmaco-mechanical procedure for acute deep vein thrombosis (DVT) in two pigs demonstrated a significant reduction...
Johnson & Johnson to acquire Shockwave Medical
Johnson & Johnson is to acquire Shockwave Medical, it has been announced today.
Under the terms of the transaction, Johnson & Johnson will acquire all...
New data show single-session Indigo aspiration system without overnight thrombolytics is safe and effective...
During the Society of Interventional Radiology (SIR) 2024 annual meeting (23–28 March, Salt Lake City, USA), newly presented data from a subgroup analysis of...
SVS announces VAM keynote speaker series
Registration for the 2024 Vascular Annual Meeting (VAM 2024) launched on March 20 and promotions teased a new annual VAM fixture: the SVS Keynote...
Study hints at long-term cost-effectiveness of CDT and PMT over oral anticoagulation for moderate...
During a presentation at the 2024 European Vascular Course (EVC; March 3–5) in Maastricht, The Netherlands, Anna Pouncey, MD, a clinical research fellow for...
Getinge and Cook Medical enter US commercial distribution agreement for iCast covered stent
Getinge and Cook Medical today announced an exclusive sales and distribution agreement for the iCast covered stent system, which recently received Food and Drug...
First-in-human study of Pounce thrombectomy system in acute iliofemoral DVT demonstrates 12-month PTS rate...
Twelve-month outcomes from the Pounce venous thrombectomy system (Vetex Medical) first-in-human study evaluating its use in the treatment of acute iliofemoral deep vein thrombosis...
Endovascular showdown: CX 2024 sets the stage for BASIL-3 first-time data presentations
At the Charing Cross (CX) Symposium 2024 (23–25 April, London, UK), Andrew Bradbury (University of Birmingham, Birmingham, UK) and the BASIL-3 team of triallists...
FDA Breakthrough Device designation granted for DynamX BTK for use in CLTI treatment below...
Elixir Medical has announced Breakthrough Device designation by the Food and Drug Administration (FDA) for its novel DynamX BTK System, an implant for use...
Personalized, precision medicine is key to the future of aortic repair
Predicting longevity in patients who may be candidates for aortic repair is challenging. This, coupled with a high and unchanging long-term postoperative mortality rate,...
Bentley, Cook Medical enter US distribution agreement for BeBack device
Cook Medical and Bentley today announced a distribution agreement for the BeBack crossing catheter in the U.S., with Cook assuming commercial responsibilities for the...
SCVS 2024: Bismuth becomes 2024–25 Society for Clinical Vascular Surgery president
Jean Bismuth, MD, took over as Society for Clinical Vascular Surgery (SCVS) president during the organization's 51st Annual Symposium in Scottsdale, Arizona (March 16–20).
The...
Hans-Henning Eckstein: 1955–2024
Hans-Henning Eckstein, the vascular surgeon who played a leading role in the SPACE and SPACE 2 randomised controlled trials on the treatment of carotid...
First patient enrolled in IDE study of Aquedeon Medical’s Duett vascular graft system
Aquedeon Medical has announced the initiation of an investigational device exemption (IDE) clinical trial to study the Duett vascular graft system.
A press release reveals...
Multi-society PAD Pulse Alliance aims to highlight importance of patient education
Society for Vascular Surgery (SVS) experts are spearheading initiatives as part of the multispecialty PAD Pulse Alliance and its Get a Pulse on PAD...
VRIC 2024 to hear from leading light on role of immunity and inflammation in...
Filip Swirski, PhD, a leading figure in cardiovascular immunology research, will deliver this year’s Alexander W. Clowes Distinguished Lecture at the 2024 Vascular Research...
New data underscore physician experience levels required to derive benefit from transfemoral carotid artery...
Data from a new study that maps out the levels at which adverse postoperative events decrease following transfemoral carotid artery stenting (TfCAS) based on...
US FDA Breakthrough Device designation granted for Biotronik’s Freesolve BTK resorbable magnesium scaffold
Biotronik has been granted Breakthrough Device designation (BDD) from the US Food and Drug Administration (FDA) for the Freesolve below-the-knee (BTK) resorbable magnesium scaffold...
Vascular external support system use found to boost key functional outcomes for surgical arteriovenous...
Alik Farber, MD, professor of surgery and radiology at Boston University, is set to present the results of a multicenter U.S. study at the...
VAM abstract submissions hit near-historic high
A nearly record-breaking 794 Abstracts were submitted for the SVS 2024 Vascular Annual Meeting (VAM 2024). The abstracts were scored by the VAM Program...
Longer fasting before venography appears to impact stent size selection, new study finds
During the 2024 American Venous Forum (AVF) annual meeting in Tampa, Florida (March 3–6), Kurt S. Schultz, MD, a general surgery resident at the...
Vascular surgery resident reflects on Match Day experience
Integrated vascular surgery resident Eric Smith, MD, tells Vascular Specialist how he handled the lead up to Match Day.
For medical students hoping to specialize...
New analysis points to lack of vascular surgical voices in news coverage of vascular...
A new study set to be aired at the 2024 Society for Clinical Vascular Surgery (SCVS) annual meeting (March 16–20) in Scottsdale, Arizona, sheds...
IVUS use in claudicants not associated with improved outcomes, claims data show
The use of intravascular ultrasound (IVUS) for the treatment of claudication doubled over a four-year period but there was “no clear relationship between IVUS...
CLOUT registry: Interim two-year rates of PTS ‘significantly lower’ than those in historical DVT...
Rates of post-thrombotic syndrome (PTS) among deep vein thrombosis (DVT) patients treated with the ClotTriever thrombectomy system (Inari Medical) who are logged in the...
Single-center analysis suggests improved longer-term outcomes with endarterectomy versus TCAR
A large, single-center analysis has found that, despite parity between the two procedures in terms of perioperative clinical outcomes, carotid endarterectomy (CEA) was associated...
ISC 2024 examines TCAR ‘explosion’ alongside advances in intensive medical therapy
This year’s International Stroke Conference (Feb. 7–9) in Phoenix, Arizona, hosted discussions on the current state of play in carotid stenosis treatment—and, most notably,...
The top 10 most popular Vascular Specialist stories of February 2024
In February, the most read stories from Vascular Specialist include a study of metformin and its potential as the first-ever medical treatment that can...
AVF 2024: Outgoing president addresses history, future direction of American Venous Forum
At the 2024 American Venous Forum (AVF) in Tampa, Florida (March 3–6), Glenn Jacobowitz, MD, professor of vascular and endovascular surgery at NYU Langone...
Non-pneumatic compression device performed better than advanced pneumatic compression for lower extremity lymphedema
A new study presented during the 2024 American Venous Forum (AVF) in Tampa, Florida (March 3–6), that compared a novel non-pneumatic compression device with...
Adoption of AI into workflow associated with faster time to assessment of PE patients
An abstract presented at the 2024 American Venous Forum (AVF) annual meeting (March 3–6) revealed that, in the treatment of patients with pulmonary embolism...
VESS 2024: Determining success in vascular surgery across the generations
Outgoing Vascular & Endovascular Surgery Society (VESS) President Mark Conrad, MD, used the 2024 VESS presidential address to illustrate how he got into vascular...
Frank J. Veith joins ViTAA Medical Solutions’ board of directors
ViTAA Medical Solutions has announced the appointment of Frank J Veith, MD, professor of surgery at the Cleveland Clinic Lerner College of Medicine of...
Endologix initiates postmarket study of the Detour system
Endologix has announced the initiation of the Percutaneous transmural arterial bypass (PTAB)1 postmarket study. This study marks the beginning of a comprehensive postmarket study...
EACTS and STS guidelines recognize aorta ‘as an organ in its own right’
New guidelines from the European Association for Cardio-Thoracic Surgery (EACTS) and the Society of Thoracic Surgeons (STS) have, for the first time, recognized the...
FORS-powered LumiGuide 3D imaging technology is rolled out at specialized centers in U.S. and...
Andres Schanzer, MD, has hailed it "one of the most exciting changes" seen in imaging during the course of his career. Philips’ LumiGuide "human...
U.S. study highlights racial and ethnic disparities in the placement of ‘overused’ IVC filters
A nationwide U.S. study, recently published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL), showed that Black patients had the highest...
Mechanical thrombectomy demonstrates superior outcomes to anticoagulation in DVT patients, analysis of RCT and...
Mechanical thrombectomy using the ClotTriever device (Inari Medical) for iliofemoral deep vein thrombosis (DVT) was found to be “associated with significantly” lower Villalta scores...
Large administrative databases enter crosshairs as comparative analysis shows percutaneous mechanical thrombectomy as superior...
The pitfalls of large administrative databases came to the fore during the presentation of a propensity-match scoring analysis demonstrating that percutaneous mechanical thrombectomy (MT)...
Nitinol stents placed in iliac veins “not associated with prolonged back pain,” study finds
In a retrospective review of over 600 patients who underwent iliac vein stent placement, the development of back pain was found to be unrelated...
Consortium led by vascular surgeon-scientist secures $6.4 million funding to develop sustainable alternative to...
The European Union Horizon Europe, with joint funding from UK Research Innovation, has awarded the NetZeroAICT Consortium €6 million ($6.4 million) in funding to...
VAM 2024 pricing now available
Pricing information for the 2024 Vascular Annual Meeting (VAM 2024) is now available. The event, scheduled in Chicago from June 19–22, is promoted as...
As temporal trends in hemodialysis access creation emerge, notion of AV fistula superiority comes...
The 2024 Southern Association for Vascular Surgery (SAVS) annual meeting (Jan. 24–27) hears three separate talks—two scientific papers and one from an invited guest...
Landmark BEST-CLI trial gains recognition as top cardiovascular advance in 2023
The American Heart Association (AHA) has named the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb ischemia) trial one of...
AAA and complex repair: ‘We need more evidence,’ says UChicago chief
A randomized controlled trial (RCT) of open repair versus endovascular aneurysm repair (EVAR) for the treatment of abdominal aortic aneurysms (AAAs), as well as...
Trial assessing AI-powered tissue microsensor technology in PAD begins enrollment
Sensome has announced enrollment of the first patients into a feasibility clinical study using the Clotild smart guidewire in peripheral arterial disease (PAD). Clotild was designated...
More than half of medical students altered Match ranking order after post-virtual interview site...
Amid the build-up to residency Match Day 2024, the Association of Program Directors in Vascular Surgery (APDVS) has delivered data from a VISIT (Vascular...
Breakthrough Device designation granted for Efemoral scaffold system designed to treat CLTI
Efemoral Medical has announced the granting of Food and Drug Administration (FDA) Breakthrough Device status for its novel Efemoral vascular scaffold system (EVSS) designed...
SAVS 2024: A journey to the heart of DEI like no other
David L. Cull, MD, delivers a captivating presidential address, laying bare his own challenging journey as a vascular surgeon and the hidden lessons on...
The top 10 most popular Vascular Specialist stories of January 2024
In January, the most read stories from Vascular Specialist include a U.S. Aortic Research Consortium analysis of F/BEVAR preoperative risk factors in AAAs/TAAAs; a...
Re-evaluating aortoiliac endarterectomy: Case series shows ‘acceptable durability’
The uncommonly performed aortoiliac endarterectomy—one of the open procedures on which the vascular surgical specialty was founded—provides acceptable durability in aortoiliac occlusive disease patients...
‘Get a Pulse on PAD’: Multi-society public awareness campaign launched
The Society for Vascular Surgery (SVS), in partnership with three other medical societies operating in the vascular disease space that form the PAD Pulse...
Measuring plaque inflammation via SCAIL scores may improve carotid stenosis risk stratification
The use of a relatively novel scoring system, referred to as Symptomatic carotid atheroma inflammation lumen-stenosis (SCAIL), has produced favourable predictive qualities versus the...
UK MHRA update: Paclitaxel-coated device increased mortality risk is withdrawn for PAD
Following a review, the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) has updated guidance on the use of paclitaxel-coated devices stating that such devices...
Serration angioplasty associated with reduced recoil in infrapopliteal arteries compared with plain balloon angioplasty
A study comparing the extent of early infrapopliteal recoil after serration and plain balloon angioplasty has found the former produces “substantially less” arterial recoil...
SVS points to 2023 achievements, challenges in coming year
The Society for Vascular Surgery (SVS) reflects on a year marked by notable achievements on multiple fronts. In a communication to members in mid-December,...
First patient enrolled in HERCULES randomized trial comparing ESAR and EVAR
The first patient has been enrolled into the HERCULES trial, which compares endosuture aneurysm repair (ESAR) to standard endovascular aneurysm repair (EVAR) in the treatment of abdominal aortic...
Could metformin be first-ever medical treatment that is effective at managing aneurysm disease?
There is a global interest in assessing whether metformin, which has a long track record of safety and efficacy, is relatively inexpensive and is...
How the best leaders ensure psychological safety at work
My limited understanding of psychological safety is when people feel safe expressing differing opinions, and thoughts in the workplace. Amy Edmondson, a pioneer in...
First patient treated in ZFEN+ fenestrated endovascular graft study
Cook Medical has announced the first patient treated in the clinical study of the Zenith Fenestrated+ endovascular graft (ZFEN+) in the U.S. The procedure was...
Mentor Match available for all SVS members
The SVS has expanded its Mentor Match program, which is now available to all SVS members in good standing. The program aims to connect...
SOOVC releases handbook for outpatient care
The SVS Sub-Section on Outpatient and Office Vascular Care (SOOVC) has released the anticipated Office-Based Lab (OBL) Handbook to guide practitioners and aid with...
Viabahn VBX stent graft receives FDA approval
Gore has announced recent Food and Drug Administration (FDA) approval of a lower profile Viabahn VBX balloon expandable endoprosthesis (VBX stent graft) for the treatment...
Endospan releases early TRIOMPHE IDE study results at Society of Thoracic Surgeons annual meeting
Endospan shared 30-day results from the first 22 patients enrolled in the TRIOMPHE investigational device exemption (IDE) study in a late-breaking presentation at the...
Southern Vascular elects first woman president-elect
The Southern Association for Vascular Surgery (SAVS) elected Margaret (Megan) Tracci, MD, to become its first ever woman president for the 2025–26 cycle.
Tracci,...
Gore receives FDA approval for breakthrough endovascular device in complex aortic aneurysms
Gore has announced Food and Drug Administration (FDA) approval for the Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE), which the company states is the first...
Coding: Increasing complexity and lost RVUs—a drop in the ocean?
A vascular surgery team at Audie L. Murphy VA Medical Center in San Antonio, Texas, uncovers “staggeringly low” numbers of correctly coded billing for...
Midterm CARAS study results show cerebral ischaemic event incidence “should not be underestimated”
The final publication of midterm results from the observational CARAS study suggest that cerebral ischaemic event (CIE) incidence in asymptomatic carotid stenosis patients “should...
University of Pittsburgh awards $100,000 grant to SVS member for AI-based healthcare project
Last October, the University Pittsburgh’s Clinical and Translational Sciences Institute hosted its 10th Pitt Innovation Challenge (PinCh), providing a total of $550,000 in prizes,...
International collaboration unveils updated PAD guidelines in diabetic foot ulcers
The International Working Group on the Diabetic Foot (IWGDF), the European Society for Vascular Surgery (ESVS) and the Society for Vascular Surgery (SVS) have...
First procedures announced in study of novel peripheral IVL system
FastWave Medical has announced the successful completion of enrollment for its first-in-human (FIH) study with the company’s peripheral intravascular lithotripsy (IVL) technology.
The prospective, single-arm...
First patients enrolled in VBX FORWARD clinical study
Gore has announced that the first patients have been enrolled in the Gore VBX FORWARD clinical study, a global prospective, multicenter, randomized controlled trial to compare...
U.S. Aortic Research Consortium maps out F/BEVAR preoperative risk factors for one-year mortality in...
A series of preoperative risk factors—including currently smoking, chronic kidney disease (CKD), congestive heart failure (CHF), aneurysm size greater than 7cm, more advanced...
The utility of renal stenting in hemodialysis patients: One in five found to come...
A fifth of patients among a chronic kidney disease (CKD) cohort on hemodialysis—a rare subset pulled from a large repository of national data—were able...
BEST-CLI: A year down the road
A dedicated session at the 2023 VEITHsymposium (Nov. 14–18) in New York City aimed to unpack the ways in which clinical practice and attitudes...
No increased risk of complications found with transradial access for carotid artery stenting
Carotid artery stenting (CAS) delivered via transradial artery access has demonstrated no increased risk of stroke, death, myocardial infarction, transient ischaemic attack, or access...
FDA approves ENGULF US pivotal trial of Hēlo thrombectomy system
Endovascular Engineering (E2) has announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for its ENGULF US pivotal trial.
The study will...
SCAI, SIR, SVS jointly publish proceedings from multispecialty peripheral IVUS roundtable
Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ultrasound (IVUS) in lower extremity revascularization procedures were released today in the...
Centers for Medicare & Medicaid Services grants Transitional Pass-Through payment for Endologix’s Detour system
Endologix recently announced that the Centers for Medicare & Medicaid Services (CMS) has granted a Transitional Pass-Through (TPT) payment for the Detour system, effective...
VAM travel scholarships open doors for underrepresented medical students
The Society for Vascular Surgery (SVS) Resident and Student Outreach Committee (RSOC) is accepting applications through Jan. 8, 2024, for the Diversity Medical Student...
Vascular Specialist’s top stories of 2023
Which stories captured the attention of the vascular community over the course of the past year? Read our summary of the trending articles from...
Corner Stitch: On the vascular trainee opportunities on the conference calendar
Christopher Audu, MD, surveys the 2024 meeting landscape, highlighting prime opportunities for trainees to showcase their research.
It is abstract submission, and this month I...
Yao family and SVS Foundation establish James S.T. Yao Resident Research Award
In a tribute to the late James S.T. Yao, MD, PhD, a luminary in the field of vascular surgery, the Yao family and the...
Nominations open for 2024 SVS Excellence in Community Practice Award
The Society for Vascular Surgery (SVS) is calling for nominations for its Excellence in Community Practice Award, which recognizes outstanding leadership within the community...
First patient treated in ARISE II study of ascending stent graft
Gore has announced the first patient implantation of the company's ascending stent graft in the ARISE II trial, describing this as an exciting step...
Personalized postoperative anticoagulation needed to curb lower-limb amputations
“We’re going to see more and more amputations if we don’t figure out the right post procedure thromboprophylaxis regime ASAP,” Anahita Dua, MD, warned...
JVS-VL to be open access beginning in January
The Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL) will move from a subscription model to one of open access—freely available online—on Jan....
SVS members pitch in to help patients kick the smoking habit
SVS members are taking advantage of the new Smoking Cessation Toolkit and resources from the Vascular Quality Initiative (VQI), adding them to existing programs...
Ego, logistics, money: Overcoming barriers to a successful wound care program
Proper integration of primary care physicians (PCPs) in the multidisciplinary care of vascular wounds is going to play an increasingly important role as the...
Society for Vascular Surgery addresses latest mainstream media reports on atherectomy
The Society for Vascular Surgery (SVS) has issued a statement addressing the latest reports published by ProPublica on atherectomy use in the U.S.
The nonprofit...
SVS receives CMSS grant to advance diagnostic excellence
The Society for Vascular Surgery (SVS) has received a $100,000 grant from the Council of Medical Specialty Societies (CMSS) to promote diagnostic excellence across...
Humacyte submits Biologics License Application to FDA seeking approval of Human Acellular Vessel
Humacyte today announced that it has submitted a Biologics License Application (BLA) to the Food and Drug Administration (FDA) seeking approval of the Human...
Less vain and more vein: Evaluating the perceptions of venous disease amongst the vascular...
Our biases permeate the fabric of our very being, as they weave their way into our training and practice. It is clear that complex...
‘There is no reliable way to measure carotid stenosis—methods have changed and tend to...
The recent move to expand Medicare coverage of carotid stenting formed the basis of a recent debate over the wisdom of the decision taken...
Need for ‘clear, well-defined guidelines’ in patient selection for surgical implantation of baroreflex activation...
The emergence of a baroreflex activation therapy device for heart failure patients is drawing in the assistance of the open surgical expertise of vascular...
Bylaws referendum approved by SVS voting members
The voting members of the SVS have approved amendments to the Society bylaws following a referendum that closed on Nov. 20. The proposed changes...
SVS makes fresh call for active participation in compensation survey
The Society for Vascular Surgery (SVS) has made a fresh call for members to participate in a compensation survey, a collaboration with Phairify, that...
Changing course: The natural history of tibial claudication comes under scrutiny as interventions for...
In the end, reflected Michael S. Conte, MD, “it’s not the evidence.” The leading vascular surgeon and peripheral arterial disease (PAD) expert made the...
Enrollment complete in APEX-AV study of mechanical aspiration system for acute PE
Patient enrollment is now complete in the APEX-AV trial evaluating the safety and efficacy of the AlphaVac F1885 (AngioDynamics) multipurpose mechanical aspiration system for...
The top 10 most popular Vascular Specialist stories of November 2023
In November, the most read stories from Vascular Specialist include a reassessment of which carotid revascularization treatment modality is best after the recent Centers...
Intravenous anesthesia delivery during varicose vein treatment proves safe and reduces pain scores, researcher...
A new intravenous anesthesia delivery technique used during endothermal ablation for varicose veins demonstrated comparatively low pain scores according to first-in-human (FIH) data recently...
VOYAGER PAD analyses shed light on use of rivaroxaban in high-risk patient populations
New analyses from the VOYAGER PAD clinical trial in both high-risk and fragile patients and those with and without comorbid coronary artery diseases (CAD)...
TRANSCEND 36-month data “continue to demonstrate safe and effective performance” of SurVeil DCB
Peter Schneider (University of California San Francisco, San Francisco, USA) recently presented 36-month data from Surmodics' TRANSCEND clinical trial at the VEITHsymposium 2023 (14–18...
VAM abstract submissions window opens
VAM program chair Andres Schanzer, MD, makes a call for cutting-edge new science for next year’s meeting in Chicago.
Researchers who want to present new...
Change: A driving force behind SVS advocacy initiatives
Change is a constant in life, and advocacy is no exception. The healthcare landscape is always evolving, and the SVS Advocacy Council is working...
The pulmonary arterial tree—it is time we branch out
Nicolas Mouawad, MD, chief of vascular surgery at McLaren Health System in Bay City, Michigan, urges vascular surgeons to “get out of their comfort...
Twelve-month first-in-human data from Xeltis’ aXess haemodialysis vascular conduit trial presented at VEITHsymposium 2023
Xeltis has announced "highly encouraging" 12-month results from its first-in-human (FIH) aXess vascular conduit trial. The data were presented by Frans Moll (University Medical...
Randomized trial set to elucidate value of image fusion technology for aortic repair
An ongoing UK National Institute for Health and Care Research (NIHR)-funded randomized controlled trial seeks to illuminate the value of an image fusion guidance...
Impact of the CMS proposed rule on the QPP for 2024
This summer the center for medicare and Medicaid Services (CMS) published its annual Physician Fee Schedule and Proposed Rule for calendar year 2024, and...
Two-year SWING data ‘continue to show promise’ for sirolimus DCB in treating BTK disease
Two-year data from the SWING trial, a first-in-human study of the safety and performance of the Sundance sirolimus drug-coated balloon (DCB; Surmodics), have been...
Specialty representation at all levels of a healthcare organization is ‘increasingly important’ in value-based...
A 14-year effort to achieve departmental status for vascular surgery at a large healthcare system in Southern California resulted in significant gains for the...
NIH-funded research on the use of AI in vascular surgery: A decade in the...
Vascular surgeon-scientist Elsie Gyang Ross, MD, recently secured coveted funding through the National Institutes of Health (NIH) Research Project Grant Program (R01)—a rare feat...
SVS executive director elected to executive council of Council of Medical Specialty Societies
The Society for Vascular Surgery (SVS) Executive Director Kenneth M. Slaw, PhD, has been elected to executive council of the Council of Medical Specialty...
Carotid disease: Getting to the right decision
The recent move by the Centers for Medicare & Medicaid Services (CMS) to expand coverage for carotid artery stenting brought with it the requirement...
DETOUR1 and DETOUR2 pooled analysis of bypass system reveals primary rate of 68.1% through...
Endologix has announced results from a pooled analysis of the DETOUR1 and DETOUR2 studies evaluating percutaneous transmural arterial bypass (PTAB) with the Detour system.
The Detour system...
PROMISE II 12-month data show durable outcomes with the LimFlow system in no-option CLTI...
One-year results from the PROMISE II US pivotal trial demonstrate the durability of outcomes of transcatheter arterialisation of the deep veins (TADV) using the...
The top 10 most popular Vascular Specialist stories of October 2023
Last month, the most popular stories from Vascular Specialist included The Centers for Medicare & Medicaid Services (CMS) confirmation of carotid artery stenting coverage expansion;...
LimFlow announces agreement to be acquired by Inari Medical
LimFlow announced today that it has entered into a definitive agreement to be acquired by Inari Medical.
A press release details that, under the terms...
Computer-assisted vacuum thrombectomy system for patients with pulmonary embolism demonstrates ‘rapid, statistically significant’ improvement...
Patients undergoing computer-assisted vacuum thrombectomy with the Indigo Aspiration System (Penumbra) for pulmonary embolism (PE) showed 2.7% rates of both major adverse events (MAEs)...
CLTI: European cohort study provides ‘strong positive evidence’ for surgery over endovascular approach, supporting...
A recently published study has shown that lower limb bypass surgery offered a significantly higher probability of amputation-free survival and wound healing compared with...
For Diabetes Month, diabetes resources for SVS members, patients
November is National Diabetes Month. Because SVS members treat patients with the condition—and its complications—the Society has numerous educational resources available.
“Diabetes and Vascular Disease”...
Akura thrombectomy system for PE appears safe and demonstrates reduction of RV/LV ratio in...
Results from a first-in-human, prospective, single-arm study of the Akura Medical thrombectomy system (Akura Medical) for pulmonary embolism (PE) were revealed this week at...
No relationship found between DW-MRI lesions and long-term stroke risk following carotid revascularisation
A secondary analysis of existing clinical trial data has indicated that new ischaemic brain lesions detected via diffusion-weighted magnetic resonance imaging (DW-MRI) following carotid...
Six-month outcomes from phase-one trial of anti-inflammatory drug to assess benefit in acute DVT...
The open-label phase of the DEXTERITY-AFP trial investigating the Bullfrog microinfusion device—which involves the perivenous injection of the anti-inflammatory drug dexamethasone to improve patency...
One-year CLOUT data demonstrate low rate of PTS following treatment with ClotTriever
David Dexter (Sentara Vascular Specialists, Norfolk, USA) shared one-year data from the CLOUT registry this week at The VEINS 2023 (28–30 October, Las Vegas,...
New varicose vein management guidelines released
The SVS, in collaboration with the American Venous Forum (AVF) and the American Vein and Lymphatic Society (AVLS), has unveiled part two of...
SVS unveils proposal outlining changes to Society bylaws
Voting members of the SVS will have the opportunity to consider a bylaws referendum, with key amendments related to membership and the composition of...
REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system compared to mechanical...
Data from the REAL-PE study were presented this week at TCT 2023 (23–26 October, San Francisco, USA) demonstrating that patients treated for pulmonary embolism...
Thrombolex announces new insights from the RESCUE trial with the Bashir endovascular catheter
Thrombolex has announced never-before-reported major reductions in obstruction in all of the segmental pulmonary arteries (PA), based on independent core lab data analysis of...
Highlighting original work by women: Peer-review title blazes new trail in vascular surgery
The September issue of Annals of Vascular Surgery featured 37 original, peer-reviewed scientific papers whose lead authors and researchers are women vascular surgeons. Here,...
Women’s champion: Freischlag marks out value of diversity and surgeons as hospital leaders
Julie A. Freischlag, MD, used her turn as honorary guest lecturer at the 2023 Midwestern Vascular Surgical Society (MVSS) annual meeting to make a...
TCT 2023: LIFE-BTK breathes life into drug-eluting resorbable scaffolds in breakthrough for below-the-knee arteries
Results of the LIFE-BTK randomized controlled trial have just been presented at TCT 2023 (Oct. 23–26) in San Francisco. The data show that, in...
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and death that helped...
Data from a patient-level meta-analysis—a factor in the Food and Drug Administration’s (FDA) recent change of position on the use of paclitaxel-coated devices to...
Survey suggests venous work less valued than arterial interventions
The majority of more than 300 vascular surgeons who responded to a recent survey indicated that they perceive the management of venous disease to...
NESVS 2023: Cambria takes over as New England SVS president
Robert Cambria, MD, recently took over as president of the New England Society for Vascular Surgery (NESVS). He was passed the presidential baton by...
Prepare to submit research for VAM 2024
Organizing a Vascular Annual Meeting (VAM) takes a whole lot of time and a whole lot of long-range planning.
Thus, members of the SVS Postgraduate...
Multicenter study points to favourable safety and efficacy of radial access for peripheral interventions
New research examining the safety and efficacy of using radial access for peripheral artery interventions has found that radial access allows early ambulation and...
NESVS 2023: Novel IVC filter retrieval device slashes procedural time and radiation exposure during...
An inferior vena cava (IVC) filter retrieval device dubbed the next-generation in removal of the venous thromboembolism-fighting tools could substantially cut procedural times and...
Vascular branding: Determining a vascular surgeon’s value
A vascular surgeon's value includes far more than direct revenues from procedures performed, said SVS member Robert Tahara, MD, recently. He told surgeons to...
SVS Foundation Board of Directors welcomes two new members to its leadership team
The SVS Foundation's Board of Directors announced the appointment of two new board members, Edith Tzeng, MD, and Palma Shaw, MD, at the board’s...
Vascular Health Step Challenge emerges as beacon of awareness and action
This September, 533 people put their feet to the ground to raise awareness about peripheral arterial disease (PAD) as part of the SVS Foundation’s...
SVS webinar covers insights learned from experiences of mass-casualty disasters
A mass shooting in Las Vegas. A bombing at the finish line of the Boston Marathon. A shooting at a Fourth of July parade....
CMS confirms broadened Medicare coverage of carotid artery stenting in final decision
The Centers for Medicare & Medicaid Services (CMS) has released its final decision regarding National Coverage Determination (NCD) 20.7 covering carotid artery stenting (CAS),...
Rates of stroke, death and myocardial infarction post-TCAR do not differ by patient sex
While sex disparities regarding the outcomes of carotid revascularization have “long been a concern,” new prospective data published in the Journal of Vascular Surgery...
SVS varicose vein guideline webinar set for Oct. 10
A virtual roundtable on Oct. 10 will cover the new Society for Vascular Surgery (SVS) varicose veins guidelines. Set for 6–7:30 p.m. CDT, the...
From the editor: Sex, lies, and carotid stents
First, a disclaimer. This commentary is woefully short of sex-related content. Not even the wholesome gender-based outcomes stuff. So, if that key term brought...
Enrollment of first patient in Neuroguard carotid stent system trial announced
Contego Medical has announced enrollment of the first patient in the prospective, multicenter PERFORMANCE III trial aimed at further evaluating the safety and effectiveness of the...
Obituary: Roger M. Greenhalgh (Feb. 6, 1941–Oct. 6, 2023)
Roger Malcolm Greenhalgh, MD, the surgeon internationally renowned for his unparalleled contribution to vascular education, training and research, died peacefully on Oct. 6. He...
EVS 2023: New data chart underrepresentation of women at the head of national clinical...
The underrepresentation of women vascular surgeons in national clinical trial leadership formed the central theme of data coming out of a new study that...
George Lavenson, Vietnam and Gulf War veteran, advocate for carotid disease screening in seniors,...
George S. Lavenson Jr., lovingly referred to as “Doc” by his many friends, died Saturday, Aug. 19, 2023, on the beautiful island of Maui,...
MVSS 2023: Human Acellular Vessel proves ‘safe, effective bypass conduit’ in complex CLTI cohort
An investigator-sponsored clinical study conducted at the Mayo Clinic in Rochester, Minnesota, of the investigational Human Acellular Vessel (HAV) in patients with chronic limb-threatening...
MVSS president outlines why vascular surgery is special and how ‘people need to know...
Outgoing Midwestern Vascular Surgical Society (MVSS) President Jeffrey Jim, MD, used his recent presidential address to call upon vascular surgeons to spread the word...
Expiation, Karl Wallenda, Oppenheimer and us
On March 22, 1978, Karl Wallenda went up on a high wire in Puerto Rico strung between two high-rise buildings. There was no safety...
The top 10 most popular Vascular Specialist stories of September 2023
Last month, the most read stories from Vascular Specialist included data releases from the recent Midwestern Vascular Surgical Society (MVSS) using direct revascularization of segmental...
EVS 2023: Putting artificial intelligence to use in vascular practice
The potential for large language-learning models like ChatGPT to take over tedious writing tasks such as emails and parts of PowerPoint presentations—or even be...
WVS 2023: President emphasizes importance of ‘tolerance’ in vascular specialty
Outgoing Western Vascular Society (WVS) President Wei Zhou, MD, used her presidential address to put out a call for the vascular specialty to embrace...
JVS-VL peer-review title launches virtual special issue on diversity topics
The Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL) has launched its first virtual special issue on diversity, equity and inclusion (DEI) in...
SVS History Digital Archive Task Force calls for notabilia
The SVS History Digital Archives Task Force is soliciting contributions as it aims to present a curated collection to SVS members and the medical...
Amplifying advocacy: SVS tool for vascular influence on the federal stage
In the dynamic arena of healthcare advocacy, the Society for Vascular Surgery (SVS) stands as a champion, harnessing the power of amplification to thrust...
Preventing spinal cord ischemia: Novel techniques for direct segmental artery revascularization show promise, WVS...
A vascular surgery team from the University of Southern California (USC) in Los Angeles demonstrated the feasibility of multidisciplinary direct revascularization of segmental arteries...
VasQ AVF creation device receives FDA clearance
Laminate Medical Technologies has announced their flagship device, the VasQ external vascular support, has been cleared by the Food and Drug Administration (FDA) for...
New clinical data support AI solution for improved PE detection and care coordination
Viz.ai has announced new clinical data supporting advancements in pulmonary embolism (PE) detection. Two studies have demonstrated the real-world clinical efficacy of Viz.ai’s PE module to...
‘Voices of Vascular’ attracts national recognition with diversity award
“Voices of Vascular,” an initiative to highlight the diverse voices within the SVS, has earned the Society and the SVS Foundation a Profile of...
Why CMS should still not extend reimbursement indications for carotid stenting or other carotid...
This commentary—authored by Anne Abbott, PhD, MBBS, Lawrence Schott, MD, Lan Gao, MMed, PhD, Hrvoje Budincevic, MD, PhD, Rishad Faruqi, MD, Tatjana Rundek, MD,...
WVS 2023: Western Vascular Society presidency passes from Zhou to Fujitani
Roy M. Fujitani, MD, president of the University of California, Irvine (UCI) Medical Center medical staff, took over as Western Vascular Society (WVS) president...
SVS-ACS Vascular Verification Program marks release of new standards for outpatient vascular centers
The Society for Vascular Surgery (SVS) and the American College of Surgeons (ACS) have released new standards for outpatient vascular centers to help them...
SAVS makes travel scholarship applications call for 2024 meeting
The Southern Association for Vascular Surgery (SAVS) has put out a call for applications from medical students and general surgery residents for 20 travel...
VRIC 2024 set for May 15
The 2024 Society for for Vascular Surgery (SVS) Vascular Research Initiatives Conference (VRIC), which concentrates on basic and translational vascular science, will take place...
Popliteal artery lesions: Two-year results from European DCB catheter registry announced
“We face a scarcity of data evaluating endovascular therapy for isolated popliteal artery lesions, known as a difficult vessel bed to treat as we...
When women are PIs: A story foretold on the vascular frontlines
“Multifactorial” issues persist in gender representation in vascular leadership and trial enrollment, leading women vascular surgeons tell Vascular Specialist.
"We would have fewer untoward side...
Humacyte announces positive top line results from Phase 2/3 trial of Human Acellular Vessel...
Humacyte has announced positive top line results from its V005 Phase 2/3 trial of the Human Acellular Vessel (HAV) in vascular trauma repair.
A...
SVS launches national smoking cessation initiative
The Society for Vascular Surgery’s Patient Safety Organization (SVS PSO) has formally launched a national smoking cessation initiative. It includes tools and resources to help physicians,...
FDA approves LimFlow system for ‘no-option’ CLTI patients
The Food and Drug Administration (FDA) today announced approval of LimFlow therapy—a novel and minimally invasive procedure designed to bypass blockages in arteries of...
MVSS 2023: Aulivola takes over Midwestern Vascular reins
Bernadette Aulivola, MD, the division director of vascular surgery and endovascular therapy at Loyola University in Maywood, Illinois, took over as president of the...
EVS 2023: Ozsvath assumes Eastern Vascular presidency
Kathleen Ozsvath, MD, a vascular surgeon at St. Peters Health Partners in Albany, New York, took over as president of the Eastern Vascular Society...
FDA clears AAA-SHAPE trial for IDE approval
Shape Memory Medical recently announced that the Food and Drug Administration (FDA) has granted investigational device exemption (IDE) for the company to begin a...
Multi-society guidelines on varicose vein management published
The Society for Vascular Surgery (SVS), American Venous Forum (AVF), and American Vein and Lymphatic Society (AVLS) have released the second and final part...
Vascular Nurses Week shines spotlight on vital role in patient care and innovation
In a world in which both medical breakthroughs and technological advancements seem to dominate the healthcare landscape, it’s easy to overlook the unsung heroes...
SVS urges members to take part in compensation survey—and bolster results
Organizers behind an SVS-commissioned financial compensation survey are calling on more members to fill out the short list of questions so that they can...
CMS: Proposed reduced conversion factor would cut vascular surgeon reimbursements
The Centers for Medicare & Medicaid Services (CMS) in mid-July released two payment-related proposed rules—the highly-anticipated calendar year (CY) 2024 Medicare Physician Fee Schedule...
Submit ideas for VAM 2024 educational sessions
Organizers of VAM 2024 want members to consider what the modern-day vascular surgeon needs to know for optimal patient care and professional success. What’s...
SVS members rally to respond to CMS carotid stenting coverage proposal
Nearly one-third of the public comments submitted to the Centers for Medicare & Medicaid Services (CMS) on a controversial proposed coverage decision affecting carotid...
Empowering vascular surgery to promote five pivotal healthcare bills before Congress
Welcome back to Government Grand Rounds, a campaign aimed at expanding vascular surgeons’ understanding of—and comfort with—the SVS’ many advocacy tools. In the dynamic...
Coding and complex PAD: Register today for two SVS courses
Limited spots remain open for two popular SVS courses coming in October: the Complex Peripheral Vascular Interventions (CPVI) Skills Course on Oct. 1–2 and...
Step off Friday for SVS Vascular Health Step Challenge
The month of September begins Friday and with it, the SVS Foundation’s Vascular Health Step Challenge.
The initiative challenges participants to walk 60 miles—representing the...
First US patient enrolled in SOCRATES short neck AAA trial
The first U.S. patient has been treated as part of the SOCRATES trial (Short neck AAA randomized trial—ESAR and FEVAR), which compares the safety...
The price of a cup of coffee
In the wake of the coverage of inappropriate vascular interventions in the mainstream press, guest editorialist Adam Tanious, MD, tackles the thorny issue of...
Endovascular stablization system for infrarenal AAAs gains FDA Fast Track designation
Nectero Medical announced that the Food and Drug Administration (FDA) has granted Fast Track designation for the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST)...
Venous stenting and the IVC: ‘Persistent problems’ in the setting of post-thrombotic syndrome
The question of “persistent problems” with venous stenting among post-thrombotic syndrome (PTS) patients emerged as a key talking point during the recent Deep Venous...
Congress considers incremental steps towards Medicare payment reform
There is no doubt that the Medicare payment system needs reform. At this moment, the SVS is aiming to inspire reform through all facets...
First patient treated in global strategic collaboration involving Cydar Maps technology
Cydar Medical has announced the successful treatment of the first patient in a strategic collaboration with Medtronic. The collaboration, which spans 40 sites across...
Clinical performance of Human Acellular Vessel amid war in Ukraine presented at military research...
Clinical outcomes of Humacyte's investigational Human Acellular Vessel (HAV) were presented at the Military Health System Research Symposium in Kissimmee, Florida (Aug. 14–17), following...
Child-bearing age ‘should not be a contraindication to venous stenting’
In a recently published study, dedicated venous stents performed well through pregnancy and postpartum, and a protocol including the use of low-dose antiplatelets in...
Study finds no correlation between IVC filter placement position and device complications
Researchers report that inferior vena cava (IVC) filter placement position relative to the level of the most inferior renal vein was not associated with...
Learn coding intricacies at October workshop on reimbursement
The SVS will host the SVS Coding and Reimbursement Workshop this fall, providing a comprehensive program designed to equip vascular surgeons and their support...
Your SVS: Executive Board sets course for year
Phase II of a national branding campaign for vascular surgery and three new task forces are just two of several initiatives the SVS’ Executive...
UCLA-SVS review course is this month
Time is running out to plan attendance at the annual course, A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery,...
Corner Stitch: Supplementing our formal learning as vascular trainees
As a vascular surgery trainee, there are multiple aspects of vascular surgery that I’ve had the opportunity to learn about. And to be honest,...
Breaking ground: A trial to improve the care of uncomplicated type B aortic dissection
Because high-quality evidence from large, prospective multicenter trials on the best treatment of uncomplicated type B aortic dissection (uTBAD) is scarce, SVS members Firas...
VQI Fellows in Training program marks one year
The Vascular Quality Initiative (VQI) Fellows in Training (FIT) program is a success, said leaders as they provided a one-year review.
FIT introduces residents and...
SVS members get ready for second annual vascular health awareness event
September's Vascular Health Step Challenge is fast-approaching, and SVS members are preparing to step up to meet it.
The challenge benefits the SVS Foundation,...
SVS responds to CMS proposed coverage expansion for carotid stenting
The Society for Vascular Surgery (SVS) and its affiliated Patient Safety Organization (PSO)/Vascular Quality Initiative (VQI) have submitted a formal response to the Centers...
WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study completes enrolment
Merit Medical has announced that it has completed enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective,...
SCVS president becomes chair of American Board of Surgery
The American Board of Surgery (ABS) has named Society for Clinical Vascular Surgery (SCVS) President M. Ashraf Mansour, MBBS, as its 2023–24 chair. He...
Light-activated drug-coated balloon granted FDA approval for clinical study
Alucent Biomedical has announced that the Food and Drug Administration (FDA) granted an investigational device exemption (IDE) for a U.S. clinical study of AlucentNVS,...
‘Vascular surgery should be a key member of pulmonary embolism response teams’
“PERT care is the coalition of the willing,” quipped Dennis Gable, MD, a vascular surgeon at Texas Vascular Associates in Plano, Texas. He was...
SVS urges members to make voices heard on CMS carotid stenting coverage expansion
The SVS has created a template to help members transmit comments to the Centers for Medicare & Medicaid Services (CMS) regarding proposed major adjustments...
‘FDA’s mission to bring safe and effective vascular surgery devices to market remains steadfast’
The Vascular and Endovascular Devices Team (VEDT) in the Food and Drug Administration (FDA) Office of Cardiovascular Devices appreciates the Vascular Specialist editorial board's...
The top 10 most popular Vascular Specialist stories of July 2023
In the previous month, Vascular Specialist delivered a range of leading commentary from the Society for Vascular Surgery (SVS) in response to the New...
Newest JVS peer-review title appoints editor-in-chief
The Journal of Vascular Surgery (JVS) has announced the appointment of Anahita Dua, MD, as the editor-in-chief of the Journal of Vascular Surgery-Vascular Insights...
Financial viability, appropriate use and patient safety in the operation of outpatient facilities
The number of office-based facilities has been increasing steadily over the past several years—and more vascular surgeons may be considering becoming involved in operating...
Comments sought on CMS proposed coverage expansion for carotid stenting
SVS members are encouraged to submit comments—due Aug. 10—to the Centers for Medicare & Medicaid Services (CMS) on its proposed national coverage determination on...
New study reports positive performance of AI-powered assessment of biomarkers for growth prediction of...
The characterization of aortic tissue by means of three key biomechanics-based biomarkers bundled into a compound Regional Areas of Weakness (RAW) Map showed “very...
Vascular surgery added as named specialty to influential national hospital rankings
U.S. News & World Report has renamed the specialty formerly known as “Cardiology & Heart Surgery” to include vascular surgery in its national rankings of...
Humacyte completes enrolment in Phase II/III trial of Human Acellular Vessel for vascular trauma...
Humacyte today announced completion of enrollment in its Phase II/III vascular trauma trial (V005) that is expected to support a Biologics License Application (BLA)...
SVS Foundation adds two surgeons to board of directors
The Society for Vascular Surgery (SVS) Foundation has announced the appointment of Bernadette Aulivola, MD, and Vikram Kashyap, MD, to its board of directors. Both...
The Golden Larva syndrome: Is it real?
Failure is part of the process that leads to success. Occasional failures may sting but we must recognize the adage that failure is a...
Nectero Medical receives FDA clearance of IND application to initiate Phase II/III clinical trial...
Nectero Medical today announced that the US Food and Drug Administration (FDA) has granted investigational new drug (IND) clearance for the company to initiate...
Endologix announces first patients treated with the Detour system
Endologix has shared in a press release that the first patients underwent percutaneous transmural arterial bypass (PTAB) using the Detour system since Food and Drug...
SVS coding workshop coming in October
The SVS’ 2023 Coding and Reimbursement Workshop will help participants learn about accurate coding and reimbursement for vascular surgery. The intensive two-day program will...
Crawford panel looks at opportunities to plug and extend vascular surgery workforce pipeline
This year’s E. Stanley Crawford Critical Issues Forum zeroed in on the pipeline of sources feeding the vascular surgery ranks. Incoming SVS President Joseph...
SVS responds to New York Times article on overuse of vascular interventions
In an official Society response, SVS President Joseph Mills, MD, tackles recent coverage in the mainstream media of inappropriateness in vascular care.
There have been...
The numbers are in: VAM 2023 adds up to another SVS classic
Landmark meeting (June 14-17) with nearly 1,400 vascular professionals moves the needle with program innovations, slew of new science and jam-packed agenda.
With more content...
Second edition of VSITE review text released
The second edition of a hit trainee-created textbook primarily aimed at those taking the Vascular Surgery In-Training Exam (VSITE) has hit the shelves.
The Vascular...
SVS seeks volunteers to write position paper
Society for Vascular Surgery (SVS) members have until July 31 to apply to serve on a new SVS writing group to develop a position...
Study finds similar rates of VTE in both flying and non-flying surgical patients
Uncertainty underlying the magnitude of risk posed by long distance air travel in venous thromboembolism (VTE) patients has created the need for a deeper,...
Long-awaited FDA update finds data do not support excess mortality risk for paclitaxel-coated devices
In a letter to healthcare providers dated July 11, 2023, the Food and Drug Administration (FDA) communicates that the risk of mortality associated with...
VESAP5 expires July 14
The SVS’ fifth edition of the Vascular Education and Self- Assessment Program (VESAP5) expires at 9 a.m. CDT July 14 and with it, the...
Review urges development of protocols to reduce hypersensitivity reactions after cyanoacrylate varicose vein treatment
Despite being considered “generally safe,” cyanoacrylate can cause local reactions in up to 25% of patients, disproportionately affecting women, Asian race and thin patients...
The top 10 most popular Vascular Specialist stories of June 2023
Last month, Vascular Specialist garnered readers' attention with an array of commentary on the BEST-CLI and BASIL-2 trials; the medical editor's interview with vascular...
Surmodics receives FDA approval for the SurVeil drug-coated balloon
Surmodics has announced the receipt of Food and Drug Administration (FDA) approval for the SurVeil drug-coated balloon (DCB).
A company press release notes that the...
FDA approves study of ZFEN+ for treatment of aortic aneurysms
The Food and Drug Administration (FDA) has granted approval for Cook Medical to initiate an investigational device exemption (IDE) study on the Zenith fenestrated+...
SVS mourns death of Past President Kenneth Wayne Johnston
The Society for Vascular Surgery (SVS) mourns the death of Kenneth Wayne Johnston, an SVS member, former president and recipient in 2009 of the...
Risk of cancer-related VTE recurrence ‘significantly lower’ using NOACs compared with low molecular weight...
Delivering results and recommendations from a systematic review and meta-analysis of novel oral anticoagulants (NOACs) versus low molecular weight heparin (LMWH) in the prevention...
Vascular Verification Program registers first four hospitals in US—including UCSF
UC San Francisco Medical Center (UCSF) is among the first four hospitals in the U.S. to be verified as part of the American College of...
Assessing the needs of young vascular patients
In the past 18 months, a joint taskforce studying the needs of pediatric vascular patients has made great strides, conducting a needs assessment, identifying...
New analysis probes BEST-CLI trial against real-world setting data
A new analysis of chronic limb-threatening ischemia (CLTI) treatment outcomes was presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions...
Primary patency after venous stenting best in NIVL patients, study finds
A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders....
Bias and the silver bullet: Gender partiality seen within AI algorithms for AAA identification
Artificial intelligence (AI) has become a central focus within various spheres, from commerce to medicine—including applications in patient care. Sharon Kiang, MD, talks to...
Advocacy exists to serve: Surgeons, patients and our mission
One of the most gratifying aspects of working to advocate for surgeons is that, at its heart, this is completely transparent and is done...
Physical pain a risk factor for vascular surgery trainee burnout, survey reveals
A recent survey has indicated that physical pain is “prevalent” among vascular surgery trainees and represents a risk factor for burnout. Eric Pillado, MD,...
VAM attendees chime in on BEST-CLI and BASIL-2
VS@VAM journalist Will Date and videographer Jean-Philippe Bensoussan caught some VAM 2023 foot traffic outside the BEST-CLI and BASIL-2: Debate, Analysis and Implementation session...
‘Vigilant’ surveillance and low threshold for further interventions ‘crucial’ following rescue of prior EVAR...
The findings of a recent study on reinterventions and sac dynamics after fenestrated endovascular aneurysm repair (FEVAR) with a physician-modified endograft (PMEG) for index...
Two-year DETOUR2 study results presented at VAM 2023
Endologix has announced the 24-month results of the DETOUR2 study, presented at VAM 2023, the annual meeting of the Society for Vascular Surgery (SVS),...
SVS announces new vice president and treasurer following 2023 election
The Society for Vascular Surgery (SVS) has announced the latest additions to its officer roll following the 2023 elections for Society vice president and...
Nephrologist insights for vascular surgeons at hemodialysis access session
Friday afternoon in Potomac D will see VAM play host to a series of presentations on access for hemodialysis that will offer education on...
Improved fistulas and cost-effectiveness promised in plenary 5 abstract presentation
Friday morning’s Plenary Session 5 (8:00–9:30 a.m.) is set to feature new data on an external support device that may deliver more functional arteriovenous...
Future research needed to ‘optimize’ use of imaging technologies during aortic procedures
Imaging technologies in the aortic space will be a key feature of Saturday’s Plenary Session 8 (11:15 a.m. to 12:30 p.m.) in Potomac A/B,...
Study shows performance on the vascular qualifying examination does not predict performance on the...
A national cohort study of vascular trainees taking the Vascular Qualifying Examination (VQE) and the Vascular Certifying Examination (VCE) found performance during the former...
Novel drug candidate for slowing AAA growth demonstrates safety in humans
The local delivery of a glucose-derived compound in small- and medium-sized abdominal aortic aneurysms (AAAs) has been deemed safe, with “promising” early efficacy data...
BEST-CLI investigators implore a move beyond endo vs. open ‘battle’ in the name of...
The principal investigators behind the BEST-CLI trial struck a conciliatory tone during the inaugural Frank J. Veith Distinguished Lecture yesterday morning in which they...
Generational divide: Do baby boomers and millennials see eye-to-eye on vascular surgery training needs?
Older-generation vascular surgeons are keen to hone their endovascular skills, while the younger generation are looking to develop their capacity to treat aortic pathologies—but...
Special VAM session underscores ‘complementary’ nature of open and endovascular strategies in CLTI patients
A dedicated session at VAM 2023 saw speakers and delegates gather to debate, analyse and consider the implementation of the BEST-CLI and BASIL-2 randomized-controlled...
Presidential address: ‘The annual meeting is only part of our story’
Friday morning will see Michael C. Dalsing, MD, MBA, deliver what is an annual hallmark of the VAM program—the SVS Presidential Address.
From 11:00 a.m.–12:15...
Carotid revascularization capable of improving mood in depressed patients with carotid atherosclerosis
A prospective study has demonstrated that carotid intervention can improve mood in depressed patients with advanced carotid disease, in addition to enabling cognitive improvements...
The global burden of CLTI: ESVS President points toward need for new global vascular...
Early-bird VAM 2023 attendees yesterday gained broad insight into the issues facing vascular surgeons around the world, with the tone set from the opening...
Cross-specialty approach to embolization ‘provides the best care for patients’
Shang Loh, MD, is chief of vascular surgery and endovascular therapy at Penn Presbyterian Medical Center in Philadelphia and professor of clinical surgery at...
Learn the who, the when and the what of treating deep vein thrombosis
Between additional available therapies, multiple new devices now on the market and evolving research supporting thrombus removal, Patrick Muck, MD, and Madhavi Meka, MD,...
VAM 2023: Vascular Quality Initiative launches national smoking cessation drive
The SVS Patient Safety Organization (SVS PSO) has launched a national smoking cessation initiative.
SVS PSO Associate Medical Director Gary Lemmon, MD, and SVS PSO...
Risk assessment models “no better than coin toss” for predicting bleeding in patients considered...
A study of two risk assessment models (RAMs) for predicting the bleeding risk in patients considered for pharmacologic prophylaxis to prevent venous thromboembolism (VTE)...
Opening ceremony heralds ‘power’ of VAM attendance
SVS President Michael Dalsing, MD, officially opened the 2023 Vascular Annual Meeting (VAM) yesterday morning, telling attendees at the early morning Opening Ceremony: “For...
VAM 2023: Vascular trauma session to highlight the current role of endovascular therapy
A focused session on vascular trauma yesterday took a deep dive into emerging issues and controversies in the field.
Moderated by Sherene Shalhub, MD, of...
Prediction model offers new option for forecasting AAA growth
A predictive model incorporating 3D shape features such as aneurysmal flow lumen and outer wall structure extracted from computed tomography (CT) imaging can improve...
VAM 2023: ‘What I wish I knew before retirement’ talk gives insight into adaptation...
Reflecting on the positives and negatives of retirement, Peter Gloviczki, MD, from the Mayo Clinic, previously in Rochester, Minnesota, now in Scottsdale, Arizona, and...
VAM 2023: Endovascular thermal septotomy for chronic post-dissection aortic aneurysm
Aidin Baghbani-Oskouei, MD, and Gustavo S. Oderich, MD, from the University of Texas Health Science Center at Houston, Texas, detail the endovascular thermal septotomy...
CEA associated with less reintervention than stenting in first six months-study
A durability study that looks at reintervention risk among patients treated with carotid endarterectomy (CEA) versus carotid artery stenting (CAS) procedures established that CEA...
Special invited research presentations offered at VAM
VAM traditionally includes presentations from specially invited translational researchers that are performing cutting-edge work focused on vascular disease. All are held during plenary sessions.
“These...
Study weighs up total transfemoral and upper extremity approaches for F/BEVAR
In a prospective, non-randomized study, researchers found that a total transfemoral approach was associated with lower rates of cerebrovascular events and improved outcomes compared...
Onco-vascular session set to offer ‘clinical pearls’ in ‘new’ area of vascular surgery
Randall DeMartino, MD, is Division Chair of Vascular and Endovascular Surgery at the Mayo Clinic in Rochester, Minnesota, and a co-moderator of a session...
Analyses offer a deeper dive into BEST-CLI trial data
As the vascular community continues to digest key insights from the BEST-CLI randomized controlled trial (RCT), attendees of Plenary Session 3 at the Vascular...
VAM 2023: SVS descends on Capitol Hill
Nearly 50 SVS members took advantage of VAM’s location near Washington, D.C., visiting Capitol Hill Tuesday to discuss legislation related to vascular surgery with...
VAM 2023: Slew of special SVS section sessions set for Thursday
The SVS includes five special sections for different member groups, including physician assistants, women, young surgeons, surgeons in community practice and the Subsection on...
Crawford panel focuses minds on challenges facing vascular surgery workforce numbers
Yesterday's E. Stanley Crawford Critical Issues Forum, which looked at ways to address the pipeline of sources feeding the vascular surgery pool of talent,...
Sex-related disparities in lower-extremity revascularization outcomes brought into focus
Women are more likely to undergo reintervention after lower extremity revascularization for peripheral arterial disease (PAD) compared to male patients with similar limb salvage...
Endothelial cell granted superhero status in invited research presentation
“The endothelial cell is the superhero of the vascular system,” Kathryn L. Howe, MD, PhD, FRSCS, a vascular surgeon-scientist at the University of Toronto...
Significant life and limb gains for claudicants who stop smoking before lower-extremity bypass
Long-term overall survival (OS) and amputation-free survival (AFS) are outcomes that rebound in claudicants who quit smoking prior to elective surgery—and they mirror those...
VAM is ‘in the room where it happens’
To borrow from the hit musical “Hamilton,” VAM 2023 takes place right near Washington, D.C., the seat of power, and “the room where it...
Safety benefits mean TCAR may be preferable approach in radiation-induced carotid stenosis
A study set to be presented at VAM (14–17 June, National Harbor, USA) has found that the long-term outcomes of transcarotid artery revascularization (TCAR)...
Base revascularization strategy on effectiveness in restoring adequate and durable limb perfusion, BEST-CLI subanalysis...
The results of a subanalysis of the BEST-CLI trial found that patients with chronic limb-threatening ischemia (CLTI) who were deemed suitable for open lower-extremity...
Global perspectives take center stage in second annual WFVS session at VAM
“The intellectual exchange of information and a better understanding of unique global perspectives has brought the leading societies closer,” Palma Shaw, MD, MBA, secretary...
Integrated vascular surgery program features may optimize trainee wellness and decrease attrition
Today’s program at the 2023 Vascular Annual Meeting (VAM) will feature the presentation of an abstract by R. Debbie Li, MD, Loyola University Medical...
VAM 2023: Learn at lunchtime
The Society for Vascular Surgery has added four lunchtime learning sessions to the VAM opening day.
Topics are both clinical and non-clinical, ranging from planning...
Study finds carotid stent fracture rate to be negligible but long-term research needed
Presenter Neeta Karani, MD, from Bronson Healthcare, Kalamazoo, Michigan, is set to elucidate findings that consider the incidence of carotid stent fractures and their...
‘First’ study to identify endothelial cell-cell communication via bidirectional secretion of extracellular vesicle cargo...
Award-winning vascular resident talks about the science behind her work, which her mentor says is “moving the needle on every front.”
University of Toronto surgeon-scientist...
VAM 2023: President-elect zeroes in on complexity of issues within vascular surgery pipeline
The Vascular Annual Meeting (VAM) E. Stanley Crawford Critical Issues Forum this year probes the problems and the challenges facing the vascular surgery workforce...
More research needed but lithotripsy plus TCAR ‘an answer’ in certain carotid disease patients
Earlier this year, researchers debuted single-center experiences indicating that intravascular lithotripsy (IVL) may be able to expand transcarotid artery revascularization (TCAR) into patients with...
The essential ‘need’ for vascular surgeons in pulmonary embolism treatment paradigm
The specter of pulmonary embolism (PE) as a common and lethal disease process—with mortality of massive PE static at about 50% for decades while...
VQI@VAM: Quality takes center stage at VQI meeting, initiative making much out of zero
Over the past several months, the Society for Vascular Surgery’s Vascular Quality Initiative (VQI) hit some important milestones, including registering procedure number 1,000,000 in...
VQI@VAM: Social media helps promote safe technique, study finds
A social media campaign promoting educational videos proved efficient and cost-effective, and similar campaigns will be useful for quality improvement projects directed toward medical...
BEST-CLI vs. BASIL-2: Different questions yield different answers
Medical editor Malachi Sheahan III, MD, takes a look at seemingly conflicting results from the landmark BEST-CLI and BASIL-2 trials, and asks what they...
‘Nobody believed us’: Vascular giant discusses overcoming skeptics to make specialty-defining breakthroughs
Malachi Sheahan III, MD, Vascular Specialist’s medical editor, speaks to living legend and limb-salvage pioneer Frank J. Veith, MD, on the contents of his...
BASIL-2 and BEST-CLI: A tale of two limb trials
Optimal treatment of patients with chronic limb-threatening ischemia (CLTI) has been an ongoing debate within the vascular community, fueled by growing numbers of patients,...
VAM 2023 beckons
Our annual gathering is almost here. After months of planning, our premiere educational event in vascular surgery, the Vascular Annual Meeting (VAM), opens June...
FDA seeks to ‘modernize’ clinical trials with new draft guidance
The Food and Drug Administration (FDA) has released draft guidance with updated recommendations for good clinical practices (GCPs) aimed at modernizing the design and...
‘Sonolysis is back’ after safely reducing endarterectomy stroke risk in randomized trial
Positive results from a clinical trial involving a novel therapeutic procedure known as sonolysis—deployed during a carotid endarterectomy (CEA)—were presented at the recent European...
The top 10 most popular Vascular Specialist stories of May 2023
Last month, Vascular Specialist most piqued reader interest with a commentary from the editor-in-chief on why he supports the decision by the Southern Association for Vascular...
Vascular surgery moves to assess trainees’ competence with EPAs
For surgeons, “EPA” means not the “Environmental Protection Agency” but “Entrustable Professional Activity”—and they’re going to change surgery training. A pilot rollout for vascular...
SVS Foundation announces 2023 student fellowship awards
The Society for Vascular Surgery (SVS) Foundation has announced the winners of the 2023 Student Research Fellowship Awards.
The award is for undergraduate college and...
SVS webinar discusses BEST-CLI and early impacts on practice
A recording of the inaugural “SVS Presents” virtual educational session, on the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb...
Interim data find ‘no evidence of benefit’ for carotid revascularization additional to optimized medical...
Interim results from the ECST-2 randomized controlled trial (RCT) have shown no evidence that carotid stenosis patients with a low-to-intermediate stroke risk, treated with...
FLAME, FLASH and ongoing PEERLESS trials collect ‘compelling’ data for FlowTriever device
Speaking on the FLAME, FLASH and PEERLESS trials that each collected data on the FlowTriever (Inari Medical) device for the treatment of pulmonary embolism...
Urban residents have smaller risk of mortality from chronic limb-threatening ischemia
A new study using data from millions of patients hospitalized across the U.S. has determined whether population density and associated urban versus suburban versus...
Advance: Navigating the policy and political processes on Capitol Hill
The underlying processes associated with advocacy—whether legislative, regulatory or political—are arduous and complex. As a result, measures of “success” are often characterized by progress...
We can honor the past without living in it
Malachi Sheahan III, MD, peels back the layers on why a decision by the Southern Association for Vascular Surgery (SAVS) to replace its signature...
Insights from largest chronic limb-threatening ischaemia study to inform quality of care improvements
Data from a cohort of one million patients with chronic limb-threatening ischaemia (CLTI) were recently presented as late-breaking clinical research at the Society for Cardiovascular...
JETi registry provides “remarkable results” for peripheral thrombectomy system
Presenting “remarkable results” from the JETi registry—a prospective, multicenter, observational study which collected real-world data on the safety, performance and clinical benefits of the...
EndoAVF found usually less cost effective compared with sAVF
The Society for Clinical Vascular Surgery (SCVS) 50th Annual Symposium (25–29 March, Miami) hosted a series of abstract presentations. Among them was one by...
Correct coding for IVUS during venous and arterial interventions
The use of intravascular ultrasound (IVUS) can provide helpful information for assessment of pre- and post-intervention vascular status and, thus, is an important part of...
Happiness, well-being and culture are key ingredients for seeking ‘eudaimonia’
Although researchers describe eudaimonia as the practice of virtues like courage, wisdom, good humor, moderation and kindness, some have translated the writings of Greek...
Medical therapy gains highlight need to reassess carotid surgery
“The time has definitely come to look at the evidence, and redo these studies,” posited Alun Davies, MD, from Imperial College London in London,...
Five-year results of the LEOPARD trial published in the Journal of Vascular Surgery
Endologix has announced the online publication of the final five-year results of the LEOPARD trial in the Journal of Vascular Surgery (JVS). The study's...
CX 2023: Statins save lives after aortic repair regardless of dose
Statin treatment after aortic repair is associated with improved long-term survival, while dose does not matter. This was the key message from a first-to-podium...
Corner Stitch: Navigating the technology landscape as a vascular trainee
I vividly recall sitting in the back of the conference room as a medical student and marvelling at the various approaches that could be...
New analysis of chronic limb-threatening ischaemia patients places BEST-CLI trial into context within real-world...
A new analysis of chronic limb-threatening ischaemia (CLTI) treatment outcomes was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography &...
A vascular mission: Defying assumptions in the fight against amputation in disadvantaged areas
Lyssa Ochoa, MD, is used to the assumptions. One: ”What a nice program you have.” Another: “It must be so nice that you can...
New ‘biopsychosocial’ roadmap set out to address PAD treatment and mental health impacts
A recent proposal has called for “whole-person, multidisciplinary interventions” after an interrogation of the interplay between lower extremity peripheral arterial disease (PAD) and mental...
Reinterventions after physician-modified endovascular grafts ‘non-detrimental’ to long-term survival
For the treatment of juxtarenal aortic aneurysms, reinterventions after physician-modified endovascular grafts (PMEGs) are non-detrimental to long-term survival. This is one of the main...
Study finds no correlation between TEVAR timing and uncomplicated type B aortic dissection outcomes
With proper patient selection, short-term outcomes of thoracic endovascular aortic repair (TEVAR) in acute uncomplicated acute type B aortic dissection (uTBAD) are similar irrespective...
Efforts to move towards routine patch closure or eversion endarterectomy among all carotid surgeons...
A nationwide cohort study of over 9,000 patients shows that the “controversial” practice of arteriotomy closure for carotid endarterectomy (CEA) is associated with an...
Primary patency after venous stenting best in NIVL patients, study finds
A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders....
CX 2023: Venous, we have a perception problem
Venous disease care has a problem with optics in the context of growth in the number of venous procedures and the spectre of inappropriate...
Study finds anatomic positioning and physical activity type can cause device fatigue in the...
A recent multicentre, prospective study has found that stent deformations are greater in the common iliac vein with higher levels of hip flexion, as...
Corner Stitch: Spotlight on VESS 2023
This month, Corner Stitch highlights one of the papers recently presented at the Vascular and Endovascular Surgery Society (VESS) 2023 winter meeting in Whistler,...
Letter to the editor: The virtue of a social media presence for surgeons in...
Dear editor,
I recently read an article in Vascular Specialist regarding the new age of the “vascular surgery influencer” that discussed how the world of...
FDA approves dissection and transection indication expansion for RelayPro stent graft system
Terumo Aortic announced that the Food and Drug Administration (FDA) has granted approval of the RelayPro thoracic stent graft device for the treatment of...
The top 10 most popular Vascular Specialist stories of April 2023
In April 2023, Vascular Specialist readers were drawn to an interview dissecting the role robotics play, and can play in the future, in vascular...
Xeltis presents six-month first-in-human data on aXess graft
Xeltis has presented “highly-encouraging” six-month data from its first-in-human (FIH) aXess vascular graft trial at the 13th Congress of the Vascular Access Society (VAS;...
Cook Medical treats first patient in first-in-human clinical trial for venous valve
Cook Medical recently announced that the first patient has been treated in a clinical study to evaluate a new venous valve designed for treating...
Help fund future of vascular health by serving on SVS Foundation Board of Directors
The Society for Vascular Surgery (SVS) Foundation seeks applicants to fill a pair of two-year terms on the Foundation Board of Directors. The term...
Government Grand Rounds: Educating through advocacy
Since the initial launch of the Cancer Moonshot in 2016, the cancer community has made tangible progress towards ambitious goals, including accelerating scientific discovery...
Navigating the red tape: A case for hybrid ORs in the VA
The United States military has access to the most cutting-edge equipment to perform its duties, so we should expect nothing less for its veterans....
Research on aortic size index as predictor of AAAs in men vs women highlights...
Seeking a better understanding of why women with ruptured abdominal aortic aneurysms (AAAs) have worse outcomes when compared with men, a new study champions...
Women’s Vascular Summit 2023: The ‘changing’ landscape of AAAs in women
Since conducting an initial U.S. population-based study of gendered abdominal aortic aneurysm (AAA) trends spanning 40 years, Indrani Sen, MBBS, an assistant professor of...
Vascular community split over ‘death’ of traditional carotid stenting
A debate between two prominent carotid interventionists—Peter Schneider, MD, professor of vascular and endovascular surgery at University of California San Francisco in San Francisco,...
BASIL-2 points towards endovascular-first revascularization strategy in CLTI patients
A question from Manj Gohel, MD, from Cambridge University Hospitals in Cambridge, England, on what the 2023 Charing Cross (CX) International Symposium audience should...
VAM 2023: Gala organizers seek auction donations
The “Great Gatsby Gala” Committee is turning its attention to gathering auction items to entice bidders in both the Live and Silent auctions.
The sky’s...
Showcasing a ‘rewarding field’: student-trainee program at VAM deals with full spectrum of vascular...
Besides being able to attend the scientific and educational sessions at the Vascular Annual Meeting (VAM), medical students and general surgery residents have an...
First implant of custom-made thoracoabdominal hybrid device in North America announced
Terumo Aortic announced the first North American implant of a custom-made hybrid device, Thoracoflo.
A press release noted that the device is used to treat...
A call to arms: Reuse of mature venous conduits urged
“Recycle that vein!”—that was the appeal from the authors of a new study that trialled the explantation of mature arteriovenous fistulas (AVFs) from patients...
Surmodics announces successful first patient use of Sublime radial access microcatheter
Surmodics has announced that Ankur Lodha, MD, an interventional cardiologist at the Cardiovascular Institute of the South in Lafayette, Lousiana, and Pradeep Nair, director...
FDA approves IDE for pivotal study of high-intensity focused ultrasound platform
The Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application for the VEINRESET multicenter pivotal study that will evaluate Sonovein...
VAM educational sessions set to cover gamut of clinical and vascular practice matters
With sessions covering a wide swath of topics important to vascular surgeons, including many proposed by Society for Vascular Surgery (SVS) members themselves, participants...
May Vascular Research Initiatives Conference program takes shape
With an emphasis on cells—structural and immune—the program for the May 10 Vascular Research Initiatives Conference (VRIC) in Boston next month is taking shape.
VRIC...
Intentional mentorship and pushing beyond representation
Chicago medical student Maria Paz, BS, discusses intentional mentorship—and why she believes it matters.
When I started medical school, I never imagined that the most...
SVS member named 2023 Presidential Leadership Scholar
Society for Vascular Surgery (SVS) member Anahita Dua, MD, has been named a Presidential Leadership Scholar for 2023.
She is one of 60 scholars in...
SVS announces officer candidates for 2023 election
The 2023 Society for Vascular Surgery (SVS) Nominating Committee has announced the candidates for the 2023 officer election. They are:
For SVS vice president,...
On 45th anniversary, CX Symposium chairman credits Chicago vascular surgical tandem for enduring success
The occasion of a seminal meeting held in Chicago by former Society for Vascular Surgery (SVS) Presidents John J. Bergan, MD, and James S.T....
Society of Black Vascular Surgeons builds bridges, connects international dots
A decade ago, if he were asked to name 10 Black vascular surgeons, says one African American vascular chief, he could have come up...
Robotic surgery: ‘We’ve missed the boat on this,’ says Houston vascular chief
An emerging program at Houston Methodist aims to help prod those practicing in the vascular surgical space deeper into the field of robotic surgery.
The...
SVS Vascular Quality Initiative passes milestone 1,000th-center mark
The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI) clinical registry recently announced it has achieved another milestone, with more than 1,000 centers...
Initial case series indicates lithotripsy can help TCAR expand into high-risk patients
Lithotripsy may hold the key to enabling more carotid artery disease patients who require calcification treatment to undergo stent placement via a transcarotid artery...
Trainees: Cases sought for three VAM sessions
Vascular trainees and medical students are invited to submit their best cases for three sessions at the Society for Vascular Surgery (SVS) Vascular Annual...
SVS-ACS verification program: Key former SVS president predicts need for additional reviewers
Former SVS President Anton Sidawy, MD, hopes the launch of the Society for Vascular Surgery (SVS) and the American College of Surgeons (ACS) “Vascular Verification...
Creating an AI-based tool to help clinicians perform precision AAA analysis
For University of Calgary, Alberta, Canada, vascular surgeon Randy Moore, MD, the route to a world of precision care for individual abdominal aortic aneurysm...
Tackling health insecurity ‘from the top down and the bottom up’
The feeling of being “uncertain, anxious and vulnerable” defines a creeping health insecurity problem riddling parts of the U.S. patient population—demographics who are underserved...
Award-winning paper finds F/BEVAR ‘feasible and safe’ in patients with failed aortic repairs
Presenting award-winning new research, Andrea Vacirca, MD, a research fellow at The University of Texas Health Science Center in Houston (UTHealth Houston), revealed how,...
The top 10 most popular Vascular Specialist stories of March 2023
In March 2023, the Vascular Specialist stories grabbing readers' attention were a response to a February letter addressing vascular surgeons' use of social media; an...
Former SVS President William Abbott, 1997–98, dies at 86
William Martin Abbott, MD, former president of the Society for Vascular Surgery (SVS), died peacefully in his home Jan. 9 after a brief illness....
SCVS 2023: DAPT linked to better post-TCAR outcomes versus other drug regimens
Recent data presentations have revealed reduced risks of stroke and mortality among transcarotid artery revascularization (TCAR) patients who receive dual antiplatelet therapy (DAPT)—both preoperatively...
Computational model found to predict early aortic abdominal aneurysm rupture
In Physics of Fluids, by AIP Publishing, researchers from the Indian Institute of Technology (BHU) Varanasi and Indian Institute of Technology Kanpur made a...
SCVS 2023: DAPT shows higher survival rate in patients with low WIfI scores, study...
A retrospective cohort study presented at the 2023 Society for Clinical Vascular Surgery (SCVS) Annual Symposium in Miami (March 25–29) has found lower-extremity bypass...
Getting medical devices to market: The future might not be now, says regulatory expert
The development of medical devices in the vascular space faces increasing challenges amid moves afoot at the Food and Drug Administration (FDA), according to...
Results from PROMISE II pivotal trial published, reinforcing ‘ transformational value’ of deep vein...
Results from the PROMISE II pivotal trial investigating transcatheter arterialization of the deep veins using the LimFlow system in so-called no-option chronic limb-threatening ischemia...
DAPT linked to better post-TCAR outcomes versus other drug regimens
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid disease...
SCVS 2023: Endovascular-first or -only approach to all CLTI patients ‘is not evidence-based care’
Michael S. Conte, MD, one of the foremost experts in the field of peripheral arterial disease (PAD), took attendees of the 2023 annual meeting...
Short neck AAAs: ‘Choosing what is best for the patient’
Navigating cases of abdominal aortic aneurysm (AAA) with short neck anatomy poses a serious challenge to vascular surgeons, but the list of potential options...
Pay SVS dues to receive SVS benefits, including VAM discount
With registration for the 2023 Vascular Annual Meeting (VAM) right around the corner, those people who have not paid their SVS 2023 dues have...
First US patient enrolled in Gore Viafort vascular stent pivotal study
W L Gore & Associates (Gore) has announced that the first U.S. patient has been enrolled in a prospective, randomized, multicenter, single-arm study with...
Getinge receives FDA premarket approval for the iCast covered stent system
Getinge‘s iCast covered stent system has received premarket approval from the Food and Drug Administration (FDA) for the treatment of patients with iliac arterial...
Act now to keep CME credits, SVS urges members
Society for Vascular Surgery (SVS) members should act now so they do not lose earned continuing medical education (CME) credits.
The American Board of Surgery...
Study highlights need for ‘continuous comparative assessments’ to guide endograft treatment decisions
A recent study comparing outcomes of endovascular aneurysm repair (EVAR) patients has reported no statistically significant differences in mortality or secondary rupture rates between...
STEVECO trial calls into question randomization in the venous stenting field
Recruitment proved to be a major challenge for the STEVECO (Stent versus conservative treatment in patients with deep venous obstruction) randomized controlled trial (RCT),...
‘Time matters’: New study finds novel EHR workflow improves timeliness in vascular care
A novel, order-initiated workflow facilitated by the electronic health record (EHR) has been shown to improve timeliness of care for vascular surgery patients, decreasing...
Analysis finds no difference in TCAR outcomes between academic, community hospitals
A new study found no difference in perioperative outcomes and incidence of adverse events at follow-up after transcarotid artery revascularization (TCAR) between academic and...
SVS, ACS launch new quality verification program
The Society for Vascular Surgery (SVS) and the American College of Surgeons (ACS) have launched the “Vascular Verification Program (Vascular-VP)," an ACS Quality Program...
Bioprosthetic venous valve: ‘We want to know that this is really working’
A key investigator in efforts to tackle chronic venous insufficiency (CVI) with an bioprosthetic venous valve replacement talks about progress being made with surgical...
Letter to the editor: The vascular influencer
Dear editor,
Reading “Likes, dislikes and reposts: The new age of the vascular surgery influencer,” by Drs. Jean Bismuth (@jeanbismuth) and Jonathan Cardella (@yalevascular), they...
Viz.ai receives FDA 510(k) clearance for abdominal aortic aneurysm AI algorithm
Viz.ai recently announced it has received Food and Drug Administration (FDA) 510(k) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm (AAA)....
ABCs for the treatment of lower-extremity acute DVTs
Ashish Gupta, MD, outlines his ABCs for confronting and treating patients with acute deep vein thrombosis (DVT) of the lower extremity, and how he...
From the SVS president: Supporting one another
The Society for Vascular Surgery (SVS) has a vision that is unwavering. We desire quality vascular care for all patients by providing our members...
SCVS 2023: Four decades of AAAs in the US: Rare epidemiological study establishes women...
Abdominal aortic aneurysm (AAA) diagnosis and repair occurs among women almost 10 years later than in men—with similar age-adjusted mortality—the 2023 Society for Clinical...
Vesteck completes first-in-human use of several Suture-Tight devices
Vesteck scientific advisory board members along with key opinion leaders from around the world have successfully completed the first three in-human cases with the...
Shockwave Medical announces US launch of new peripheral IVL catheter
Shockwave Medical announced the full U.S. commercial availability of the Shockwave L6 peripheral intravascular lithotripsy (IVL) catheter following clearance by the Food and Drug Administration (FDA).
A...
SVS member elected to RUC committee
SVS member David Han, MD, has been re-elected to the American Medical Association (AMA) Relative Values Scale (RVS) Update Committee (RUC). Han’s two-year term...
Corner Stitch: What I wish I had known in vascular training
Welcome newly matched vascular surgery residents into the fold! I am just over six months into my first attending position after completing my residency...
Government Grand Rounds: Culture of engagement
Welcome back to Government Grand Rounds, where the Society for Vascular Surgery (SVS) Advocacy Council discusses how sustained advocacy engagement is important for all...
SVS launches web-based perioperative care guide
The Society for Vascular Surgery (SVS) has launched its “Management Guide on the Perioperative Care of Patients with Vascular Disease,” a multidisciplinary resource for...
Venous stenting: ‘We need to evaluate use, appropriateness and clinical indication’
An analysis of venous stent usage trends in the United States from 2014 through 2021 showed a “significant increase” in stents per day placed...
Distal embolic protection linked to significantly better outcomes in carotid stenting
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death...
Algorithm predicts females have higher risk for kidney damage after aneurysm repair
When receiving treatment for abdominal aortic aneurysm (AAA), female patients have a higher risk for kidney damage after endovascular repair, a Michigan Medicine study...
VAM 2023: Early-bird registration opens
Meeting registration and hotel reservations opened March 15 for the Society for Vascular Surgery (SVS) 2023 Vascular Annual Meeting (VAM). This year’s premiere educational...
EU ministers approve changes to MDR transition timetable
The European Union’s Council of Ministers has today adopted a resolution to extend the deadline for the certification of medical devices under the Medical...
New VOYAGER PAD analysis confirms consistent benefit of low-dose rivaroxaban plus aspirin following lower...
Data from a new prespecified analysis of the phase III VOYAGER PAD clinical trial show that low-dose rivaroxaban plus aspirin resulted in a 33%...
‘Voices of Vascular’ series celebrates Women’s History Month
The contributions of the Society for Vascular Surgery’s women members take center stage this month as part of the SVS Foundation’s “Voices of Vascular”...
ACC 2023: Large bore mechanical thrombectomy reduces adverse outcomes in high-risk PE patients
Large bore mechanical thrombectomy with the FlowTriever system (Inari Medical) in patients with high-risk pulmonary embolism (PE) was associated with a significantly lower occurrence...
Apply for Brandeis health policy program by March 15
Society for Vascular Surgery (SVS) members have until March 15 to apply for a scholarship to attend the Executive Leadership Program in Health Policy...
RESCUE trial shows reduction in segmental and main pulmonary artery occlusions
Robert A. Lookstein, MD, who is executive vice chair, Diagnostic, Molecular and Interventional Radiology at the Icahn School of Medicine at Mount Sinai Hospital...
‘SVS Presents’ provides enhanced learning opportunities
The Society for Vascular Surgery (SVS) will debut “SVS Presents” April 12, a monthly webinar series that provides an evening of educational programming for...
AVF 2023: Results from first US trial of Sonovein delivered
The 2023 annual meeting of the American Venous Forum (AVF) heard the final results from the first U.S. trial of the emerging varicose vein...
The top 10 most popular Vascular Specialist stories of February 2023
In February 2023, the hits with Vascular Specialist readers included positive safety and efficacy findings from the PRESERVE trial; the announcement of the scientific program...
VESS 2023: pMAC score found to be ‘important predictor’ of CLTI revascularization outcomes
Having observed a strong relationship between calcification and subsequent limb loss, a research team led by investigators from the University of California San Francisco...
AVF 2023: FLASH registry suggests ‘favorable safety and effectiveness profile’ in high-risk PE patients
Among 61 high-risk pulmonary embolism (PE) patients followed through to the 30-day visit in the U.S. cohort of the FLASH registry, no mortalities were...
AVF 2023: Investigators report update on three-year first-in-human results for bioprosthetic venous valve
Researchers in Colombia behind the first-in-human study of a novel bioprosthetic venous valve designed to treat chronic venous insufficiency (CVI) reported three-year results among...
AVF 2023: One-year analysis of CLOUT registry reveals ‘significant and sustained’ long-term clinical improvements
Interim one-year outcomes from the multicenter, prospective, single-arm CLOUT registry investigating use of the ClotTriever thrombectomy system in all-comer patients with deep vein thrombosis...
New study demonstrates IVC filters ‘safe and effective’ in treating venous thromboembolism
Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...
‘Urgent action needed’ to improve implementation of guideline-directed medical therapy for PVI
Almost one-half of the patients receiving a peripheral vascular intervention (PVI) in the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry between...
BioGenCell begins recruitment for clinical trial of stem cell-based treatment for preventing limb amputation
BioGenCell has announced that it is recruiting for an international clinical trial to assess the company's stem cell-based therapy for chronic limb-threatening ischemia patients...
SVS DEI Committee launches ‘Voices of Vascular’ series
To help celebrate the diversity in the vascular surgery specialty, the Society for Vascular Surgery Diversity, Equity and Inclusion Committee has launched “Voices of...
More than a research project: The vascular trainee’s role in tackling disparities in peripheral...
One of my earliest clinical experiences with vascular disease was as a high school student shadowing at a busy urban hospital in Detroit. A...
March’s free-access articles in JVS, JVS-VL
The March issues of the Journal of Vascular Surgery (JVS) and JVS: Venous and Lymphatic Disorders (JVS-VL) include eight articles that will be available...
VAM 2023 meeting set to take place as exclusively in-person event
A block party on opening day, session recordings available daily and—of course—the educational and scientific sessions for which the Society for Vascular Surgery’s Vascular...
Strategic planning session outlines SVS priorities for coming year
Key leaders from the society for Vascular Surgery (SVS) gathered in mid-January for a two-day Strategic Board of Directors (SBOD) meeting to work through...
Likes, dislikes and reposts: The new age of the vascular surgery influencer
The brave new world of social media, with its TikToks and Kardashians, has now invaded our once-sane specialty. No, this is not a veiled...
The case for aggressive intervention on symptomatic carotid web
The lead investigator behind new research from a center in Louisiana outlines how his new study—believed to be the largest single-institution analysis of symptomatic...
New Government Grand Rounds series highlights how perspective matters in advocacy
Matthew Sideman, MD, and Megan Marcinko, MPS, unveil new advocacy column aimed at drilling into the actions of Congress, and how they impact vascular...
Biotronik launches Oscar multifunctional peripheral catheter
Biotronik has announced the Food and Drug Administration (FDA) 510(k) clearance and CE mark of its Oscar (One Solution: Cross. Adjust. Restore) multifunctional peripheral...
SVS annual meeting introduces early-bird registration
The SVS is introducing a three-tiered pricing plan for the 2023 Vascular Annual Meeting (VAM). Early-bird rates start when registration opens March 15.
The cost...
Five-year outcomes of ESAR in patients with short neck
Cohort analysis shows no migrations, a low rate of ruptures, and positive sac regression, researchers say.
Five-year outcomes in patients with short neck abdominal aortic...
Educate, educate, and educate again: The continuing quest for appropriate venous care
Prominent venous disease experts discuss venous stenting, appropriate care, and the pursuit of refined data and better education in a space where part of...
VRIC: ‘High value placed on supporting young researchers,’ 2022 trainee awardee says
Warm and inviting. Plenty of engagement at each presentation. A straightforward format that allows everyone to participate at all presentations. Sense of unity. Great...
The top 10 most popular Vascular Specialist stories of January 2023
In January 2023, most popular among the Vascular Specialist readers were several stories from the recent Southern Association for Vascular Surgery meeting, including a report of data shared to demonstrate...
Patients with claudication receive more ‘aggressive’ surgical management in high-competition regions, study finds
Demonstrating the “susceptibility” of care delivery to regional market competition, M. Libby Weaver, MD, presented the case that intermittent claudication (IC) is a “novel...
New book penned by vascular icon charts career in surgery, revolutionary spirit
A new memoir penned by former Society for Vascular Surgery (SVS) President and vascular surgery leader Frank J. Veith, MD, which touches on...
Equivalency to clinical practice ‘varies considerably’ across recent carotid intervention trials
The transferability to real-world clinical practice of contemporary randomized controlled trials (RCTs) investigating carotid artery stenosis interventions “varies considerably,” according to a recent analysis...
SVS: Pay 2023 dues to avoid lapse in benefits
Members, have any of you missed your most recent issue of Journal of Vascular Surgery (JVS)? If so, it could be because your 2023...
Abbott announces agreement to acquire Cardiovascular Systems
Abbott and Cardiovascular Systems (CSI) have announced a definitive agreement for Abbott to acquire CSI. Under terms of the agreement, CSI stockholders will receive...
Spotlight: SVS members take up new positions, make endowment
Sean Lyden, MD, is now chief medical consultant for VESTECK and has joined the VESTECK Scientific Advisory Board. VESTECK is an early-stage medical device...
SVS Foundation board approves latest pilot programs to help underserved
The SVS Foundation has awarded grants to two Society for Vascular Surgery (SVS) members to help them serve the underserved as part of the...
Coding: New CPT codes for percutaneous arteriovenous fistula creation
For the 2023 Current Procedural Terminology (CPT) code set, two new codes (36836 and 36837) have been added that describe percutaneous arteriovenous (AV) fistula...
Sex found to be ‘important variable’ in study and treatment of carotid atherosclerosis
A systematic review and meta-analysis have demonstrated “convincing evidence” that sex differences exist in carotid atherosclerosis, with all types of plaque features—including those relating...
Vascular surgery oral boards text seeks to fill certifying void
Think of it as the omega of the vascular surgical textbook literature, quips Andrew M. Wishy, DO. As a training resource, it fits neatly...
PRELUDE-BTK subanalysis highlights superior lumen gain, greater volumetric blood flow using serration angioplasty
Cagent Vascular has announced the results of a comparative subanalysis of the PRELUDE-below-the-knee (BTK) study versus plain balloon angioplasty.
The study was led by Marianne...
Sudanese vascular association readies for first-ever conference
The Sudanese Association of Vascular Surgeons (SudAVaS) has announced the scientific program behind its first-ever international conference, marking the occasion by celebrating the “first...
First patient enrolled in DEFIANCE trial of the ClotTriever system in DVT
Inari Medical announced that the first patient has been enrolled in DEFIANCE, a prospective randomized controlled trial (RCT) comparing the clinical outcomes of patients...
SVS Foundation: Get ‘Gatsby’ Gala tickets today
Tickets—both individual and for tables—are selling faster than a Gin Rickey during Prohibition for the Society for Vascular Surgery (SVS) Foundation’s “Great Gatsby Gala,”...
VESAP5: Now up to 25% off
With the expiration of the fifth edition of the Vascular Education and Self-Assessment Program (VESAP5) in July, the Society for Vascular Surgery (SVS) is...
NIH funding for vascular surgeon-scientists: ‘We need more funded vascular surgeons and better coverage...
Presenting at the 2023 Southern Association for Vascular Surgery (SAVS) annual meeting in Rio Grande, Puerto Rico, Amin A. Mirzaie—a pre-medical student at Emory...
High-risk venous stasis ulceration patients show similar healing rates after multi-modal surgical therapy
A single-center evaluation of contemporary, multi-modal surgical therapy for venous stasis ulceration (C6 disease) suggests high-risk patients showed similar healing rates at one year,...
Has the risk in the value-based payment model been sold as another ‘shiny new...
Value-based payments (VBP), or “volume to value,” was the new buzz word over a decade ago, promising yet another chimera in ways to reimburse...
Back to basics: All the things I love about vascular surgery
Recently, after completing a difficult open aortic operation with my attending, a bright M3 asked me, “Why vascular surgery?” The question didn’t catch me...
‘Unique’ vascular meeting set to update surgeons, prioritize audience debate
Prioritizing “entertaining and informative” sessions, the 29th Annual Pennsylvania Hospital Vascular Symposium and the 3rd Annual Pennsylvania Hospital/University of Pennsylvania Non-invasive Vascular Laboratory Symposium...
Get FIT: Applications for VQI Fellowship in Training program open
The Fellowship in Training (FIT) from the Society for Vascular Surgery’s Vascular Quality Initiative (SVS VQI) introduces residents and fellows in vascular-focused programs to the...
The year in review: 2022 was an amazing 12 months for SVS
Despite any number of challenges, the Society for Vascular Surgery (SVS) had a hugely successful 2022 and looks forward to a bright 2023.
Executive Director...
SAVS reveals 2023–24 officeholders, including new president-elect
The Southern Association for Vascular Surgery (SAVS) officially announced its 2023–24 slate of officeholders following the conclusion of the recent SAVS annual business meeting.
The...
New SVS series zeroes in on government’s impact on vascular surgery
Starting next month, the Society for Vascular Surgery (SVS) will begin a series of articles focusing on how the actions of Congress and regulatory...
BEST-CLI: Analysis finds correlation between WIfI stage four CLTI and reports of poorer mental...
The BEST-CLI dataset has revealed a correlation between wounds, ischemia and foot infection (WIfI) stage and poorer quality of life due to mental, rather...
Surmodics provides regulatory update related to FDA premarket approval application for SurVeil
Surmodics recently announced it has received a letter from the Food and Drug Administration (FDA) related to its premarket approval (PMA) application for the...
Bentley launches rebranded crossing catheter
Germany-based endovascular device company Bentley announced the launch of the BeBack crossing catheter—formerly known as the GoBack—designed for the treatment of heavily calcified lesions...
Human-tissue engineered blood vessels remain durable at six years in PAD patients, latest study...
Mid-term results from a phase II study of surgical bypass using the Human Acellular Vessel (HAV) demonstrated an overall secondary patency rate at 72...
JVS group: Further changes in store for 2023
The planned changes for 2023 for the Journal of Vascular Surgery publications continue the momentum that began in mid- 2022. As former Editor-in-Chief Peter...
SVS unveils latest addition to JVS family of publications
The year 2023 promises to be one of change for the Journal of Vascular Surgery (JVS) family of publications, including the introduction of a...
SVS ends 2022 with latest ‘Week of Action’ to prevent Medicare payment reductions
The Society for Vascular Surgery (SVS) issued its thanks to December “Week of Action” participants.
Once again, SVS members showed incredible support for the Society’s...
SVS Foundation: ‘Gatsby’ Gala tickets on sale
Book your trip to the Roaring Twenties early, and save some money, perhaps for auction items. Early-bird ticket sales for the Society for Vascular Surgery...
SAVS 2023: President reveals upcoming change to Society seal
Southern Association for Vascular Surgery (SAVS) President William D. Jordan Jr., MD, used a portion of his 2023 Presidential Address to outline ways in...
SVS Foundation changes name of program aimed at providing care for underserved patients
The Society for Vascular Surgery (SVS) Foundation program formerly known as VISTA has a new name. VISTA—an acronym for Vascular Volunteers In Service To...
The top 10 most popular Vascular Specialist stories of December 2022
Among the most-read Vascular Specialist stories in December 2022 were the promising results from a postmarket surveillance study of a paclitaxel DCB; the Society...
SAVS 2023: Study points toward CKD patients who would most benefit from renal artery...
A new study probing which chronic kidney disease (CKD) patients would benefit most from renal artery stenting points toward those who experience a more...
SAVS 2023: Planned and unplanned vascular assists found to improve outcomes
An award-winning paper presented at the 2023 Southern Association for Vascular Surgery (SAVS) annual meeting in Rio Grande, Puerto Rico, established an association between...
Membership clears bylaws changes
The Society for Vascular Surgery (SVS) voting membership voted to approve proposed changes to the bylaws that will change the composition of the Society’s...
Deadlines coming for scholarships, grants, awards
Deadlines arrive by March 1, with some as early as this month, for a number of Society for Vascular Surgery (SVS) and SVS Foundation...
Viz.ai launches AI-powered Viz Vascular Suite
Viz.ai has announced the launch of Viz Vascular Suite—artificial intelligence (AI)-powered software enabling vascular care teams to automatically detect and triage care for suspected pulmonary...
Medtronic announces first enrollment in head-to-head global randomized trial evaluating durability of EVAR
Medtronic has announced the first patient enrollment in the ADVANCE trial, a head-to-head randomized controlled trial of two leading aortic stent graft systems, the...
ESVS AAA guidelines alert recommends ‘enhanced surveillance’ in patients treated with Nellix device
In a newly released “focused update” to their 2019 recommendations, the European Society for Vascular Surgery (ESVS) abdominal aortic aneurysm (AAA) guidelines writing committee...
Deadline extension: VRIC 2023 abstracts now due Jan. 18
The Jan. 11 deadline to submit research abstracts on vascular disease and treatment for the 2023 Vascular Research Initiatives Conference (VRIC) has been extended...
SVS webinar on 3D printing showcases how technology could affect current and future practice
The recording of the Society for Surgery (SVS) webinar on three-dimensional (3D) printing in vascular surgery is now available on the SVS website.
The SVS...
Penumbra launches Lightning Flash mechanical thrombectomy system
Penumbra have announced the Food and Drug Administration (FDA) clearance and launch of its Lightning Flash mechanical thrombectomy system.
“Lightning Flash features Penumbra’s novel Lightning intelligent...
Medicare payments: Congress fails to #StopTheFullCut
Despite intense pressure from the entire healthcare provider community, Congress failed to include provisions in its year-end legislative package to fully prevent Medicare payment...
Envision, private equity and patient care: Substituted values 2.0
He was only 41, already burdened with multiple health problems. Diabetes, hypertension and renal failure had put him on dialysis, caused the amputation of...
Summit dedicated to tackling key issues related to women’s vascular health and female workforce...
Linda Harris, MD, is a prolific attendee on the national and regional vascular meeting circuit, a noteworthy academic vascular surgeon with trainees and papers...
Vascular community starts process of wrestling with findings from BEST-CLI
One of the earliest multispecialty public gatherings of the vascular community following the release of the first results from the BEST-CLI randomized controlled...
Learning culture, errors and Melinda French Gates
Workplace culture is fascinating to observe because it is nebulous and hard to measure. There is also often a perceived gap between the existing...
Varicose vein registry analysis finds women benefit from endovenous ablation with fewer complications
An evaluation of the Vascular Quality Initiative’s (VQI) Varicose Vein Registry (VVR) carried out by the Midwestern Vascular Surgical Society (MVSS) has found women...
Meta-analysis of PTS finds one in five at risk of long-term symptoms following isolated...
A meta-analysis is first to report the pooled risk of post-thrombotic syndrome (PTS) after isolated distal deep vein thrombosis (DVT). Researchers revealed a one-in-five...
Women’s Vascular Summit: Diving into issues around women’s vascular health and the female workforce
The Women’s Vascular Summit was established five years ago with the twin purposes of delving deeper into the issues that surround women’s vascular health...
SVS mourns passing of former president
Society for Vascular Surgery (SVS) members are mourning the death of James (Jimmy) S.T. Yao, MD, 88, former SVS president and Lifetime Achievement Award...
Students and residents: Attend VAM 2023 on a scholarship
Medical students and general surgery residents have the chance to change their lives. Perhaps they are still seeking some direction for their medical careers. Perhaps...
‘Impressive’ 12-month Flex vessel prep data presented at VEITHsymposium
VentureMed Group, a medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for peripheral arterial disease (PAD), announced...
VSGBI spotlights data-driven financial incentives for PAD revascularization
The President’s Symposium at the Vascular Society of Great Britain and Ireland (VSGBI) annual scientific meeting (Nov. 23–25) in Brighton, England, saw Rob Sayers,...
SVS issues membership dues reminder
To avoid a lapse in their benefits, Society for Vascular Surgery (SVS) members are encouraged to pay their 2023 member dues by Dec. 31.
These...
Paclitaxel DCB performs well in ‘challenging anatomy’ of femoropopliteal in-stent restenosis, VQI registry data...
The IN.PACT Admiral drug-coated balloon (DCB) shows promising results in treating femoropopliteal in-stent restenosis (ISR) in a Society for Vascular Surgery (SVS) Vascular Quality...
Voting on SVS bylaws revisions ends Dec. 18
Active and Senior Society for Vascular Surgery (SVS) members in good standing have until Dec. 18 to cast their ballots to change the composition...
Efemoral Medical closes financing round to fund ongoing study of its vascular scaffold system
Efemoral Medical has today announced the closing of its $4.9 million preferred Series A1 round. Supported by existing investors as well as an experienced...
EU Commission to propose delay to MDR implementation
Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the transition period for the implementation of the European Union’s (EU) Medical Device...
Endologix receives FDA approval of PMA supplement for AFX2 system
Endologix recently announced that it has received Food and Drug Administration (FDA) approval for a premarket approval (PMA) supplement relating to the AFX2 system.
According...
Corner Stitch: A reflection on 2022…
This month's column chronicles the exciting year we’ve had here at Corner Stitch. As the section editor, I’ve been most proud of the various...
The 10 most popular Vascular Specialist stories of November 2022
Among November's most read Vascular Specialist stories were updates from the BEST-CLI trial in the form of new data and funding; a guest...
WVS 2022: New evidence of radiation reduction benefit emerges
Surgical augmented intelligence in the form of 3D mapping during complex aortic procedures can decrease radiation exposure, fluoroscopy time and contrast use when combined...
EVS 2022: Weaving magic in academic vascular surgery at JVS
Past Journal of Vascular Surgery (JVS) group editor-in-chief Peter Gloviczki, MD, invoked his hobby of magic to help illustrate what it requires to take...
Veterans Affairs: A call to surveillance
For many of those injured in combat, the transition in care from the Military Health System (MHS) to the Veterans Health Administration (VHA) can...
MVSS 2022: Study finds no link between frailty score and surgical site infection
A vascular surgery-specific composite frailty score was not associated with with risk of surgical site infection in patients undergoing lower-extremity revascularization in a review...
EVS 2022: New study shows ‘encouraging increase in academic footprint of female-driven research’
How does vascular surgery compare to other specialties in the growth of gender diversity in published research? “Are we leaders in the field, or...
For SVS Foundation Gala, prepare to return to the Roaring 1920s
Attendees at the 2023 SVS Foundation Gala will be taking a trip 100 years back in time—to the Roaring Twenties and Prohibition.
The “Great Gatsby...
Conference watch: Submit research to VRIC, VAM
Submissions already are open for 2023 Vascular Research Initiatives Conference (VRIC), which will be May 10, 2023, in Boston. The conference includes abstract sessions,...
Vascular trainee-developed VSITE review book sees sales soar
A new review textbook developed by a vascular surgery resident with the aim of helping fellow trainees prepare for milestones like the Vascular Surgery...
SVS 10-year research goals: Why create research priorities?
As was the case with the 2011 set, researchers hope the updated priorities will serve as a starting point to align research efforts within...
SVS reveals research priorities for next decade
The Society for Vascular Surgery (SVS) Research Council has updated its top 10 research priorities, originally published in 2011, with patient-centered outcomes and personalized...
SVS vascular leaders: Cohort four of Leadership Development Program selected
Twenty-nine people have been selected for development as future leaders of the profession and the Society for Vascular Surgery (SVS).
They represent cohort four of...
NESVS 2022 Presidential Address: ‘We can create a bold new future for vascular surgery:...
“Collaborate, innovate, mentor, champion DEI and relish the opportunity to form deep connections with our amazing patients.” This was the key take-home message...
BEST-CLI: Optimal medical therapy adherence ‘well below’ recommended level at baseline
A significant proportion of patients enrolled in the BEST-CLI trial did not meet optimal medical therapy (OMT) guideline-based recommendations at the time of their...
Dec. 12 webinar to examine 3D printing for vascular imaging
Society for Vascular Surgery (SVS) members can learn some of the ins and outs of three-dimensional (3D) printing for vascular imaging at a webinar...
Roundtable on varicose veins guidelines set for Dec. 6
A virtual, multidisciplinary and interactive roundtable discussion on varicose veins will be held Dec. 6.
The free roundtable, set for 6 to 7:30 p.m. CST,...
Vascular surgeons: The ‘oncologists’ of the surgical arena
Like any good presentation I feel obligated to start with my disclosures: 1) I am married to a woman who decided to pursue a...
Swiss parliament votes to accept FDA-approved medical devices
The Swiss Federal Assembly has voted in favor of accepting medical devices with the Food and Drug Administration (FDA) marketing authorization in Switzerland.
A motion...
Diversifying clinical trials: ‘There needs to be some kind of cultural competency’
The COVID-19 pandemic exposed lingering mistrust in the U.S. healthcare system among patients from minority communities as physicians continue to confront the conundrum of...
Eastern Vascular gathering challenged to forge next generation of evolution
Evolution was the core theme of the Presidential Address Robert Rhee, MD, delivered from the Eastern Vascular Society (EVS) annual meeting stage in Philadelphia...
Bright future predicted for JVS internship program
This month on Corner Stitch, Christopher Audu, MD, profiles a new and innovative program offered by the Journal of Vascular Surgery (JVS). It’s called...
Miss the SVS webinars? Take advantage of the recordings
The Society for Vascular Surgery (SVS) hosts a number of Town Halls, roundtables and webinars for the benefit of its members.
In the past few...
Deadline extension: SAVS extends travel scholarship application cut-off for 2023 meeting
The Southern Association for Vascular Surgery (SAVS) has announced a deadline extension to Dec. 5 for 20 travel scholarships that are available to medical...
VAM 2023: Apply for international scholars program by Dec. 31
Young vascular surgeons from outside the United States and Canada have until Dec. 31 to apply for scholarships to attend the 2023 Vascular Annual...
Spotlight: SVS members in the news
Several SVS members have been making moves recently, attracting recognition in the form of awards and promotions.
Katherine Gallagher, MD, of the University of Michigan,...
Viz.ai announces positive new data from large aortic dissection AI real-world study
Viz.ai recently announced new data from a large aortic dissection artificial intelligence (AI) real-world study that supports the use of its AI technology for the detection...
First-in-human patients continue to benefit from VenoValve at average of three years post-surgery, new...
Positive long-term, three-year observational data from a cohort of patients that participated in the previously concluded VenoValve (Envveno Medical) first-in-human clinical trial were recently...
Complete SVS member priorities survey by Nov. 22
To help the Society for Vascular Surgery (SVS) chart a path into the future, members—and non-members alike—are asked to complete an ongoing survey by...
SWING trial 12-month data: Novel sirolimus DCB shows ‘great promise’ in ‘challenging’ CLTI population
The Sundance (Surmodics) sirolimus drug-coated balloon (DCB) has an “excellent” safety profile in a “challenging, real-world, predominantly CLTI population,” and has a primary...
VEITHsymposium panel probes ‘value’ of artificial intelligence in vascular surgery
A session at the 2022 VEITHsymposium in New York City (Nov. 15–19) focused on new concepts, machine learning, and artificial intelligence (AI) in vascular...
The top 10 most popular Vascular Specialist stories of October 2022
The most-read Vascular Specialist stories in October covered an investigation of thoracic endovascular aortic repair (TEVAR) timing presented at the Eastern Vascular Society (EVS)...
Veterans Day: Remembering Korea, ‘accidental pioneers’ and M*A*S*H
During November—Nov. 11, specifically—the United States salutes and honors all those who have served this country in its armed forces. This November, the Society...
New diversity, equity and inclusion pillar signals additional priority for SVS Foundation
The Society for Vascular Surgery (SVS) Foundation has been guided by the three long-term pillars of research and innovation, community vascular care and patient...
Chocolate Touch DCB for treatment of peripheral arterial disease receives FDA approval
Genesis MedTech Group announced that the Food and Drug Administration (FDA) has approved the Chocolate Touch drug-coated balloon (DCB) percutaneous transluminal angioplasty (PTA) catheter...
NESVS Robert R. Linton Lecture features complex aortic masterclass from Europe
World-leading aortic surgeon Stéphan Haulon, MD, from the Aortic Centre at Hôpital Marie Lannelongue in Paris, France, took attendees of the 2022 New England...
SOOVC sub-section introduces two awards
The Society for Vascular Surgery's sub-section for those who provide service in outpatient settings has created two professional development opportunities for its members, a...
CMS: An update on quality measures for vascular surgery
An upcoming national reporting change/addition from the Centers for Medicare and Medicaid Services (CMS) includes three important elements of which Society for Vascular Surgery...
SVS adds ‘service’ criterion to Distinguished Fellows process
The Society for Vascular Surgery (SVS) has added service to the Society as an important component of its Distinguished Fellows process, an honor annually...
First data from BEST-CLI bring surgical bypass into the forefront of discussion for patients...
The first results from the BEST-CLI randomized controlled trial (RCT) of 1,830 patients show that surgical bypass with adequate single-segment great saphenous vein (GSV)...
SVS asking members to expand diversity in Nominating Committee
The Society for Vascular Surgery (SVS) will ask voting-eligible members to consider three revisions to article X of the SVS bylaws that would take...
Amplifi vein dilation system continues to show promise following latest first-in-human study update
An update from the first-in-human study assessing the Amplifi vein dilation system (Artio Medical) was delivered by Surendra Shenoy, MD, from Washington University School of...
Virtual visits versus in-person: Telemedicine study detects ‘substantial’ cost savings for patients
Virtual consultations appear comparable to care received in-person when it comes to clinical outcomes as well as patient and practitioner satisfaction, a systematic review...
‘Significant’ increase in atherectomy use in US largely driven by office-based procedures, VQI data...
In the United States, atherectomy use in peripheral vascular interventions (PVIs) “more than doubled” from 2010 to 2019, with office-based procedures a “major driver”...
Disrupt PAD III observational study results confirm safety and effectiveness of IVL in complex...
The final 1,373-patient cohort analysis from the Disrupt PAD III observational study (OS) demonstrates consistent intravascular lithotripsy (IVL; Shockwave Medical) outcomes in complex and...
End-stage CLTI: Deep-vein arterialization procedure demonstrates amputation-free survival rate of 66% at six months
Six-month results from the PROMISE II trial of the LimFlow deep-vein arterialization system showed an overall amputation-free survival of 66%—“well above” the primary endpoint...
BEST-CLI attracts $3.3m funding injection to continue data analysis
The Novo Nordisk Foundation has made a $3.3 million contribution toward the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb...
CEA, TCAR ‘continue to show superior outcomes’ to transfemoral stenting
Researchers led by a vascular team in Indianapolis found that carotid endarterectomy (CEA) remains the most-used strategy in carotid revascularization, with CEA and transcarotid...
SurVeil DCB demonstrates sustained durability of safety, efficacy endpoints in TRANSCEND
In the TRANSCEND clinical trial, the SurVeil drug-coated balloon (DCB; Surmodics) demonstrated "excellent efficacy and safety" out to 24-month follow-up. This is according to...
New analysis: Four multicenter trials support primary use of drug-coated balloons over bare metal...
A patient-level, propensity-adjusted comparison of three-year results from a quartet of prospective, multicenter trials support the primary use of drug-coated balloons (DCBs) versus bare...
‘Excellent’ three-year results presented for the BioMimics 3D stent in longer lesions
At the 2022 Vascular Interventional Advances (VIVA) meeting (Oct. 31–3 Nov. 3), Michael Lichtenberg, MD, from Arnsberg Clinic, Arnsberg, Germany, reported a subgroup analysis...
Mechanical thrombectomy for DVT: Randomized data needed to boost growing evidence base
Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022 (Oct. 30–31) in Las Vegas—the latest results...
Abre stent data show ‘struggle to maintain patency’ among post-thrombotic syndrome patients
The Abre venous stent demonstrated three-year primary patency rates of 97.1%, 76.5% and 70.4% respectively for non-thrombotic iliac vein lesion (NIVL), acute deep vein...
An open letter to the National Rifle Association
Hello,
I think it is time we talked about guns. I know you don’t like to discuss these things after a school shooting, so I...
A recent snapshot of pediatric vascular trauma injuries
A study of major pediatric vascular injuries delivered in the Vascular and Endovascular Surgery Society (VESS) Paper Session during the 2022 Vascular Annual Meeting...
Study: Combined antiplatelet, NOAC use linked to worse limb outcomes after suprainguinal bypass
A new analysis that found combined antiplatelet and novel oral anticoagulant (NOAC) therapy after suprainguinal bypass was associated with worse limb outcomes and equivalent...
Gore completes first-in-human implants of Viafort vascular stent
W. L. Gore today announced the first implants of its investigational Gore Viafort vascular stent as part of a recently initiated pivotal clinical study for...
The top 10 most popular Vascular Specialist stories of September 2022
September's top stories featured news of a trial to evaluate women's experience of early endovascular aneurysm repair, and of a special women-focused edition...
MVSS 2022: Research on hemodialysis access surgery attracts inaugural Midwestern Vascular disparities award
The authors behind a new study that found “significant differences” in hemodialysis vascular access outcomes after first-time arteriovenous (AV) fistula or graft creation “directly related” to...
‘Week of Action’ raises awareness of SVS advocacy activities
From sending emails to lawmakers, posting on social media to amplify legislative issues, and donating to the Society for Vascular Surgery Political Action Committee...
Regional vascular presidents measure state of specialty
Vincent Rowe, MD, and Raghu Motaganahalli, MD, delivered Presidential Addresses at the Western Vascular Society (WVS) and the Midwestern Vascular Surgical Society (MVSS) that...
Slew of regional vascular societies welcome new leaders for 2022–23
A number of regional vascular societies across the U.S. and Canada introduced their 2022–23 slew of officers during their annual meetings across the fall...
CX Aortic Vienna: Onus on industry to meet clinician desire for devices that function,...
The need for vascular companies to home in on developing longer-lasting devices—perhaps even ones that adapt over time to match patients’ changing anatomies—was underscored...
Vascular practice: Financial wellness is focus of Nov. 2 SVS webinar
Responding to members’ requests for more information on financial education, a nationally known estate and tax attorney will provide information and guidance on financial...
SVS weighs in on 2023 Medicare payment rules for physicians and hospital outpatient services
The Society for Vascular Surgery (SVS) has submitted comment letters in response to the proposed rules issued by the Centers for Medicare and Medicaid...
NESVS 2022: Study illustrates relationship between increased distance from medical center and higher treatment...
Research detailing that patients traveling farther for complex aortic surgery have higher procedural costs, postoperative imaging costs, and comprehensive one-year costs was among the...
Signal-to-noise ratio: Thoughts on fine-tuning feedback during vascular surgery training
I recently took the Registered Physician in Vascular Interpretation (RPVI) exam. While studying for it, one of the concepts that stood out was the...
Prepare to submit research for VAM, VRIC 2023
The Society for Vascular Surgery (SVS) wants members’ research on vascular disease for the 2023 Vascular Research Initiatives Conference (VRIC) and the 2023 Vascular...
SVS prepares for important member survey to be held in November
The Society for Vascular Surgery (SVS) will survey members in November to continue to track demographic changes, how members would like the SVS to...
SVS officer elections 2022: A glimpse into the electorate
The SVS Executive Board highlights details of the most recent Society for Vascular Surgery (SVS) elections to inform members and further strengthen the process.
In...
Only a few seats remain for CPVI hands-on skills course
Only a few spots remain available for the Society for Vascular Surgery’s new Complex Peripheral Vascular Intervention (CPVI) Skills Course. Today—Thursday, Oct. 20—is the...
EVS 2022: Study suggests lower rates of aortic rupture, mortality after TEVAR for uncomplicated...
Thoracic endovascular aortic repair (TEVAR) carried out for uncomplicated type B aortic dissections (TBAD) saw worse mortality and aortic-related outcomes when performed in the...
Mortality drops for acute type A aortic dissection, still high for patients not receiving...
The chance of a patient surviving after an acute type A aortic dissection has improved significantly, but mortality remains high if not recognized early and repaired...
ABRE clinical study 36-month data show ‘long-term durability’ of venous stent system
Medtronic has announced the 36-month final results from the ABRE clinical study. The purpose of the ABRE clinical study was to evaluate the safety and...
Six-month data from SWING below-the-knee, first-in-human trial presented at AMP Europe
Six-month data from the Surmodics SWING first-in-human (FIH) study of the company’s Sundance sirolimus drug-coated balloon (DCB) were shared at the 2022 Amputation Prevention Symposium (AMP) held Oct....
Interacting with EMR best practice advisory ‘significantly’ improves AAA screening rates
Positively interacting with best practice advisory notifications is correlated with an increased rate of abdominal aortic aneurysm (AAA) screening, according to an analysis of...
Vascular surgeons step up for PAD awareness campaign in September
Walking is instrumental to keeping the 60,000 miles of blood vessels in the human body healthy—especially for patients with peripheral arterial disease (PAD). That...
Roundtable for treating CLTI: GLASS will make it clear
The final of three roundtables on treating Chronic Limb-threatening Ischemia (CLTI) will cover the Global Limb Anatomic Staging System—GLASS.
The virtual roundtable, on GLASS staging...
Terumo Aortic announces new technology add-on payment for Thoraflex Hybrid device in US
The Centers for Medicare and Medicaid Services (CMS) has granted approval of a new technology add-on payment (NTAP) for Terumo Aortic’s Thoraflex Hybrid device—used...
FLASH results demonstrate ‘excellent safety profile’ of the FlowTriever system in full US cohort
Results of the FLASH registry demonstrate the “excellent safety profile” of the FlowTriever system (Inari Medical) in 800 real-world patients.
This is according to Catalin...
New study indicates cost-effectiveness of Denali IVC filter over Option device
Tilting or hooking occurred significantly less often in the process of retrieving the Denali inferior vena cava (IVC) filter than with the Option IVC...
VEITHsymposium to include world federation session
The World Federation of Vascular Societies (WFVS) is set to hold a session in November during the VEITHsymposium in New York City. The 90-minute session...
Trainees step up to learn coding, reimbursement
The Society for Vascular Surgery’s (SVS) efforts in coding and reimbursement work have taken another step forward, with four new doctors now in training...
Ukrainian surgeons present clinical update on Human Acellular Vessel in vascular trauma at ESVS...
Humacyte recently announced the presentation of a clinical update on the Human Acellular Vessel (HAV) for the treatment of vascular trauma. The update was...
SVS launches program to ‘REACH 535’ lawmakers
To leverage the power of direct engagement with lawmakers on the part of constituents, the SVS advocacy team is launching a grassroots advocacy plan...
ESVS publishes ‘pioneering’ clinical practice guidelines on radiation safety
The European Society for Vascular Surgery (ESVS) has released clinical practice guidelines on radiation safety, which the writing committee notes are the first guidelines...
No time like the present: The moral imperative for advocacy in vascular surgery
“I’m so sorry but we have to cancel your surgery”—10 words any warm-blooded surgeon dreads uttering. This time around, it was not for the...
Corner Stitch: Audible Bleeding cuts down to vascular core
Many Corner Stitch readers subscribe to Audible Bleeding, the vascular surgery podcast for updates on all things vascular—from vascular knowledge, to reviewing key Journal...
SVS advocacy in action: Protecting and advancing the interests of vascular surgery
Deep in to the second half of the year, there is no rest for the weary regarding Society for Vascular Surgery (SVS) advocacy initiatives....
Experts establish international standard set of outcome measures for patients with VTE
The International Consortium for Health Outcomes Measurement (ICHOM) venous thromboembolism (VTE) working group has developed a standard set of outcome measures for patients with...
WVS 2022: Study probes who benefits from EVAR among patients with chronic kidney disease
Patients with advanced chronic kidney disease (CKD) represent a high-risk group who may not benefit from elective endovascular aneurysm repair (EVAR) for abdominal aortic...
Annals of Vascular Surgery announces special issue dedicated to original work by women
The Annals of Vascular Surgery peer-review journal has announced an upcoming special issue dedicated to original work by women that is set to be...
Society for Vascular Surgery Vascular Quality Initiative celebrates one million procedures
The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI) clinical registry announced this week it has now collected more than one million procedures...
Aortobifemoral grafting in the endovascular era: An exploration of the open procedure and its...
Aortobifemoral grafting for aortoiliac occlusive disease (AIOD) probably remains “very safe” in the era of endovascular repair, according to the senior author behind a...
WARRIORS randomized trial aims to examine early EVAR in women
This month a multinational collaboration of researchers received endorsement from the Global Cardiovascular Research Funders Forum (GCRFF) Multinational Clinical Trials Initiative for the WARRIORS...
Treating PAD: ‘Run, don’t walk, to sign up for this incredible course’
No matter if you’re a surgeon with a few years—or a few decades—of experience, faculty members of a new, upcoming Society for Vascular Surgery...
PAD: Endovascular revascularization ‘superior or not significantly different’ in terms of outcomes versus open...
A real-world analysis of peripheral arterial disease (PAD) patients in Canada indicated open revascularization may not offer a long-term benefit over endovascular intervention. In...
Black patients wait more than twice as long as White patients for rAAA repair,...
Black patients saw significantly delayed care for ruptured abdominal aortic aneurysms (rAAAs), with a Vascular Quality Initiative (VQI) analysis showing a median time from hospital...
TCAR: First patient enrolled in ROADSTER 3 post-approval study
Silk Road Medical has announced enrollment of the first patient in ROADSTER 3, which the company claims is the the first prospective, multicenter, single-arm...
The top 10 most popular Vascular Specialist stories of August 2022
The top 10 most-read stories on the Vascular Specialist website in August included a look at the state of diversity, equity and inclusion (DEI)...
Trial supports full-dose anticoagulation to prevent blood clots in COVID-19 patients
Treatment of critically ill COVID-19 patients with full-dose anticoagulation lowers the risk of venous and arterial clotting complications by 44% compared with the standard dose, according to late...
SVS meets AMA membership requirement, retains House of Delegates seat
The Society for Vascular Surgery (SVS) has exceeded the necessary compliance threshold required to retain its seat in the American Medical Association (AMA) House...
Clinical outcomes of the ClotTriever system in DVT set to be evaluated in RCT
Inari Medical has announced planned enrollment of the DEFIANCE randomized controlled trial (RCT), which is designed to compare the clinical outcomes of patients with...
Researchers study role of frailty in post-discharge mortality
Society for Vascular Surgery (SVS) members have developed new methods and tools to assess patient frailty and possible surgical outcomes more simply before patients...
Shape Memory Medical completes enrollment in the AAA-SHAPE early feasibility study
Shape Memory Medical has announced the completion of patient enrollment in AAA-SHAPE, the company’s prospective, multicenter early feasibility safety study of the Impede-FX RapidFill...
Retrospective study is ‘first to systematically explore predictors of venous stent occlusion’
New data indicate that venous stent failure “may be predicted by low peak flow velocity and post-thrombotic changes in inflow veins” and that endovascular venous...
A brilliant plan to increase vascular surgeons’ income—and decrease the incidence of stroke!
I have come up with a brilliant plan that will decrease the incidence of stroke nationwide, provide an excellent source of income for vascular...
VQI analysis links high levels of neighborhood deprivation to more severe PAD
Patients categorized as living in neighborhoods with high levels of disadvantage under the Area Deprivation Index (ADI) measure of community adversity have more advanced...
Engaging with primary care providers ‘critically important’ to improving AAA screening
Matthew Mell, MD, has spent a lot of time looking into issues around screening for abdominal aortic aneurysms (AAAs). The problem, says the chief...
Study is first to elucidate lower-limb amputation epidemiology in a Latin American low- and...
A study recently published in the World Journal of Surgery claims to be the first to provide comprehensive population-level data on the epidemiology of lower-extremity...
Maximize reimbursement: Learn latest in coding at SVS workshop
When it comes to coding, information gaps can lead to revenue gaps. Proper coding and documentation are integral to receiving appropriate reimbursement for vascular...
Tying healthcare waste and spending to productivity incentives
A 74-year-old woman was recently hospitalized for a pulmonary embolus from acute deep vein thrombosis (DVT) of the mildly edematous left lower leg. She...
SVS charts its course ahead for diversity, equity and inclusion
Society for Vascular Surgery (SVS) President Michael Dalsing, MD, has added two more liaisons—Vincent Rowe, MD, and Palma Shaw, MD—to the SVS Executive Board...
Navigating EMRs: SVS webinar to demonstrate how to make them work for vascular surgery
Vascular surgeons can learn how to make electronic medical records (EMRs) work for them at a webinar Sept. 7. The webinar, sponsored jointly by...
DEI initiatives in vascular surgery: How are we doing?
The 2022 Vascular Annual Meeting (VAM) has been touted as the most diverse to date. As attendees ourselves, we can attest to the increased...
Diversity gains momentum at JVS
The addition of a diversity, equity and inclusion (DEI) editor at the Journal of Vascular Surgery (JVS) was found to be associated with more...
Key differences in presentation, outcomes for distal versus proximal DVT uncovered
A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep...
SVS addresses pair of critical payment-related proposed rules
In July, the Centers for Medicare and Medicaid Services (CMS) released two critical payment-related proposed rules for CY2023—the highly anticipated Medicare Physician Fee Schedule...
Limb salvage in focus: New VAM lectureship, born of a pioneering spirit, thrills honoree
It all started around the late 1970s, early 1980s. Back then, recalls Frank J. Veith, MD, the notion of aggressively pursuing limb salvage in...
CX Aortic Vienna: Cardiac, vascular surgeons collaborate at the vanguard of aortic care
CX Aortic Vienna returns in October for its third edition (Oct. 24–26, Digital), bringing together world-leading specialists from the cardiac and vascular fields...
Innovation within the Veterans Health Administration
If one were to ask the average citizen where cutting-edge technology is developed, the most probable answer would be “private industry”; think Apple, Tesla,...
AngioDynamics announces FDA clearance of expanded indications for Auryon atherectomy system
AngioDynamics recently announced receiving Food and Drug Administration (FDA) 510(k) clearance of an expanded indication for the Auryon atherectomy system to include arterial thrombectomy.
The FDA recently...
Vascular experts establish appropriate use of IVUS in peripheral interventions
Royal Philips today announced an important milestone in the evolving standard of care for treating patients with peripheral vascular disease: the establishment of the first-ever...
Patient-reported outcomes in vascular surgery are here to stay
In 2022, the Centers for Medicare and Medicaid Services (CMS) is again emphasizing the importance of patient-reported outcomes (PROs) through legislation regarding the Quality...
Selution SLR receives second FDA IDE approval
Selution SLR, MedAlliance’s sirolimus-eluting balloon, has received conditional Food and Drug Administration (FDA) investigational device exemption (IDE) approval to initiate its pivotal clinical trial...
CLTI: Translating guidelines into practice
Clinical practice guidelines (CPG) are integral to helping achieve optimal patient care. The Society for Vascular Surgery (SVS) clinical guidelines are evidence-based and the...
Gore acquires InnAVasc Medical
Gore has announced the acquisition of InnAVasc Medical, a privately held medical technology company focused on advancing care for patients with end-stage renal disease...
JACC study makes case for expanding coverage for carotid artery stenting
Research from Ochsner Health published in the Journal of the American College of Cardiology (JACC) is likely to influence expanded insurance coverage for carotid artery stenting.
The...
Compression duration affects pain during superficial venous intervention, study finds
Postprocedural compression of one to two weeks after superficial venous incompetence (SVI) treatment is associated with reduced pain compared with a shorter duration. This...
Confessions of a dual-trained, dual-practicing vascular-trauma surgeon
Like most of the other readers of Vascular Specialist, I look forward to perusing each release for not just useful information but also insightful...
SVS Vascular Health Step Challenge asks surgeons to walk the walk
Most American adults take an average of 5,000 steps per day. In fact, this simple act—getting out and moving—can be the key to prevention...
Vascular Specialist@VAM–July/August Review Edition
In this VAM 2022 conference review issue:
Diversity gains momentum at the Journal of Vascular Surgery (p. 1 and 4)
SVS walking challenge—Vascular Health...
New data suggest patients at AAA repair thresholds can be safely deferred
Data from the PROVE-AAA cluster-randomized trial (Preferences for open versus endovascular repair of abdominal aortic aneurysm) of a novel decision aid to assist...
APDVS president reflects on training challenges of COVID-19, ‘supply and demand’ conundrum of the...
"There are not enough vascular surgeons to do the work our specialty provides." Those are the stark words of Jason T. Lee, MD, president...
Corner Stitch: A letter to new vascular interns
Every intern starting vascular surgery this year is incredibly talented, and soon to be a member of a tight-knit, supportive, and fiercely passionate group...
Proposals sought for VAM 2023
Members are still raving about the 2022 Vascular Annual Meeting (VAM) even while organizers seek topics for educational sessions for the 2023 edition. Proposals...
Leadership program applications due by Aug. 15
Learn to be a leader or enhance your leadership skills—applications to be part of the fourth cohort of the Society for Vascular Surgery (SVS)...
Pioneering center reports ‘moderate’ success rate with Fiber Optic RealShape technology in first 50...
Vascular surgeons from the medical center that pioneered use of the radiation-lowering Fiber Optic RealShape (FORS) imaging modality reported a 62% technical success rate...
Enrollment begins in PERSEVERE clinical trial of hybrid prothesis for aortic dissection
Artivion announced today that it has initiated enrollment in the PERSEVERE clinical trial to determine if patients with an acute DeBakey Type I aortic dissection...
Intraoperative vascular mapping during hemodialysis access ‘should be incorporated into routine practice’
Intraoperative ultrasonographic venous mapping is a useful tool to evaluate vessel suitability for arteriovenous fistula (AVF) creation, Yana Etkin, MD, associate professor of surgery...
Black adults treated for common arterial disease are at greater risk of amputation, death...
About 6.5 million Americans over the age of 40 suffer from peripheral arterial disease (PAD). In the U.S., Black adults in their 50s are...
Female sex is associated with reintervention and mortality following elective EVAR
Women are more likely to die within five years of having elective surgery to repair an abdominal aortic aneurysm (AAA) or need repeat surgery, according to...
Prepare for Board exams at UCLA/SVS review course
Planning to take the upcoming Vascular Surgery Board (VSB) exams? Prepare for them at the “Seventh Annual UCLA/SVS Symposium: A Comprehensive Review and Update...
SVS PA Section seeks Steering Committee members
The Society for Vascular Surgery (SVS) Physician Assistant (PA) Section seeks applicants for its Steering Committee. The committee will be developing content for section...
SVS looks to maintain AMA House of Delegates representation
To maintain its seat in the American Medical Association (AMA) House of Delegates—and, importantly, be able to provide information that impacts physician reimbursement—a 20%...
Female sex is associated with additional treatments following surgery for intermittent claudication, study shows
A new U.S. study has found that female sex is associated with more reinterventions after surgical treatment for intermittent claudication. Additionally, guideline-directed medical therapy,...
Cordis announces start of enrollment in RADIANCY clinical study in Europe
Cordis has announced the start of the European RADIANCY premarket clinical study of a stent system designed for radial access in the treatment of...
AVeVA study confirms benefit of covered stent placement in graft-vein anastomotic stenosis treatment
A prospective, multicenter study involving the Covera vascular covered stent (BD) has confirmed the benefits of immediate, post-percutaneous transluminal angioplasty (PTA) placement of the...
The top 10 most popular Vascular Specialist items of June 2022
June's top stories spanned a range of presentations from the 2022 Vascular Annual Meeting (VAM) in Boston (June 15–18), covering topics including burnout...
PAD: Ra Medical Systems receives FDA 510(k) clearance for the Dabra 2.0 catheter
Ra Medical Systems has announced receipt of Food and Drug Administration (FDA) 510(k) clearance for the company’s Dabra 2.0 catheter as part of the...
First patient enrolled in Wrapsody endoprosthesis registry study
Merit Medical has announced the successful enrollment of the first patient in its WRAP registry study in a press release. The study will evaluate...
Cognitive dissonance, unhappy physicians and burnout
Emotional intelligence has been widely accepted as an important element of leadership. The seminal work of Daniel Goldman informs us that the education of...
Mentorship: Why more vascular surgeons should consider mentoring young minds
Addressing challenges of diversity and inclusion within medical schools and the larger physician workforce should begin with a conversation about the intrinsic barriers to...
Artificial intelligence can predict risk of complications after endovascular aneurysm repair
Artificial intelligence (AI) models can be developed to predict the risk of postoperative complications after endovascular aneurysm repair (EVAR) with “high accuracy,” research presented...
Outgoing SVS president’s message of unity: ‘We must work together to improve, advance vascular...
The Society for Vascular Surgery (SVS) is no longer the organization it was half a century ago. That was one of the core messages...
Jonathan Towne honored with SVS Lifetime Achievement Award
An “amazing clinician and leader.” Devoted to the specialty of vascular surgery. Investigator and researcher. Champion of the in-situ technique for lower-extremity bypass. Former...
Terumo Aortic announces first commercial implant of Thoraflex Hybrid in US
Following the recent approval by the Food and Drug Administration (FDA) of the Thoraflex Hybrid frozen elephant trunk (FET) device for the treatment of...
Cydar Medical and King’s College London partner on randomized controlled trial of Cydar EV...
Cydar Medical has partnered with King’s College London to initiate the ARIA study—a randomized controlled trial to assess the clinical-, technical- and cost-effectiveness of...
SVS creates limb salvage-focused Frank J. Veith Lectureship
Next year’s Vascular Annual Meeting (VAM) will include a new named lecture: the Frank J. Veith Lecture, named in honor of former Society for...
Vascular surgery review book seeks to plug hole in VSITE preparation process
When University of Massachusetts Medical School integrated vascular surgery resident Thomas Creeden, DO, was preparing for his first Vascular Surgery In-Training Exam (VSITE), it...
Bolstering the workforce: Session details how to start a vascular training program
The workforce shortage issues set to plague vascular surgery over the next few decades, alongside an aging population and increase in vascular disease, formed...
Off-the-shelf branched endograft for TAAAs demonstrates safety and effectiveness through two years in both...
Two-year target vessel-related freedom from all-cause and aneurysm-related mortality for an off-the-shelf multibranched endovascular device for the treatment of thoracoabdominal aortic aneurysms (TAAAs) came...
New SVS president outlines priorities for his tenure as Society aims to reach out
Michael Dalsing, MD, who took over as Society for Vascular Surgery (SVS) president at the 2022 Vascular Annual Meeting (VAM) in Boston (June 15–18),...
New project will develop nanoparticles with imaging and medicine-delivery capabilities to better treat PAD
A University of Texas at Arlington bioengineer is leading a project to develop biodegradable nanomaterials that will take pictures and deliver medicine to combat...
ALI can occur with or without atherosclerotic disease, portends worse prognosis in COVID-19 patients,...
Acute limb ischemia (ALI) can occur with or without atherosclerotic disease and portends a worse prognosis in patients with COVID-19. This risk persists after...
Greenberg Lecture raises prospect that ‘less is more and more is less’ with aortic...
Jan S. Brunkwall, MD, from the University of Cologne in Cologne, Germany, delivered the Roy Greenberg Distinguished Lecture at the 2022 Vascular Annual Meeting...
Vascular Surgery Interest Groups propel students’ awareness and engagement in the specialty, VAM 2022...
A study of the impact of Vascular Surgery Interest Groups (VSIGs) can have on piquing awareness and engagement of medical students in the specialty...
An antidote for burnout: Vascular surgeons as hospital administrators
The much-maligned electronic health record (EHR)—sometimes referred to as electronic medical record, or EMR—is not among the causes of burnout, per se, but rather...
Female sex ‘should be considered an independent risk factor’ for new stroke occurrence after...
A preliminary report lends evidence to support female sex being considered as an independent risk factor for new stroke occurrence after carotid revascularization in...
Study of post-carotid endarterectomy surveillance prompts protocol discussion
The results of an analysis of nearly 2,000 carotid endarterectomies (CEAs) “challenge the notion” that patients benefit significantly from the current post-operative surveillance guidelines,...
VAM 2022 Opening Ceremony: ‘Our Society is what it is because of you,’ SVS...
From the first Vascular Annual Meeting (VAM) that featured just eight papers, to VAM 2022 with many more times that number of presentations, each...
First results from BEST-CLI poised to reveal ‘very low’ quality of life for patients...
An analysis from the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial presented at the 2022 Vascular Annual...
Systemic heparin during TEVAR deemed safe for selected traumatic brain injury patients
The use of systemic heparin during thoracic endovascular aneurysm repair (TEVAR) for blunt thoracic aortic injuries (BTAI) appears to be safe in selected patients...
Diversity in care: ‘From being exclusive to more inclusive’
The role diversity played in the past, how it functions in the present, and where it might take vascular surgery in the future formed...
New findings support benefits of structured discharge approach for post-discharge transition of care
Researchers have found that restructuring the discharge process of a vascular surgery service decreased escalation to clinical staff from an automated post-discharge phone call...
Study demonstrates feasibility, effectiveness of at-home exercise therapy plus cognitive behavior therapy for IC
A mobile phone-administered, home-based exercise therapy program for patients with intermittent claudication (IC) incorporating cognitive behavior therapy (CBT) was found to be feasible, with...
Humacyte provides update on patients treated at front-line hospitals in Ukraine with the Human...
Humacyte today announced that the first Ukrainian patients have received implants of the Human Acellular Vessel (HAV) for the treatment of vascular trauma injuries....
Carotid stenting demonstrates comparable short- and long-term results to endarterectomy
Pooled patient-level data from more than 2,500 asymptomatic, non-octogenarian subjects have shown that carotid artery stenting (CAS) achieved comparable short- and long-term results to...
Eagleton and Shutze: SVS members elect new vice president, secretary
The Society for Vascular Surgery (SVS) announced that Matthew Eagleton, MD, has been elected as the organization's next vice president. The news was revealed...
Getting the most out of meetings like VAM
It’s Friday at Vascular Annual Meeting (VAM) 2022 in Boston! Hopefully, many of us trainees are getting to mingle and meet leaders in the...
Iliac vein stenting should remain a viable treatment option for higher BMI patients
Despite greater comorbid conditions, patients with obesity benefited as much as patients with normal body mass index (BMI) from iliac vein stent placement for...
Six years, much growth and multiple changes to JVS publications
Their terms about to end, Peter Gloviczki, MD, and Peter Lawrence, MD, editor-in-chief and senior editor, respectively, of the Journal of Vascular Surgery family...
Talking about women surgeons’ lives and careers
Women—and more than a few men—flocked to the inaugural Vascular Annual Meeting (VAM) education session of the Society for Vascular Surgery’s new Women’s Section...
Vascular surgeons ‘have a role to play’ in transcatheter aortic valve replacement procedures
Vascular surgery assistance in transcatheter aortic valve replacement (TAVR) can facilitate safe and effective device introduction through cases involving challenging femoral or iliac access....
F/BEVAR has high technical success and low mortality in chronic post-dissection TAAA
Fenestrated/branched endovascular aneurysm repair (F/BEVAR) is associated with high technical success and low mortality in patients with chronic post-dissection thoracoabdominal aortic aneurysm (PD-TAAA). This...
Low rate of new white lesions detected after TCAR using diffusion-weighted MRI
New white lesions are not a common occurrence in patients who have undergone transcarotid artery revascularization (TCAR), a study in which patients were assessed...
Medicare cuts: ‘It is crucially important we stay engaged in the process’
Society for Vascular Surgery (SVS) members deemed payment and reimbursement among the top advocacy priorities for 2022. A session Wednesday at VAM informed attendees...
Trust, transportation, insurance hamper ‘quality vascular surgery care for all,’ Crawford Forum hears
An absence of patient trust in their doctors and hospital systems yesterday morning emerged as a key talking point amid a comprehensive deep dive...
Researchers report higher three-year amputation and reintervention rates in Black and Hispanic CLTI patients
In a study of over 7,000 chronic limb-threatening ischemia (CLTI) patients, researchers found that Black and Hispanic patients had higher three-year amputation and reintervention...
Silk Road to evaluate TCAR in standard surgical risk patients with ROADSTER 3 study
Silk Road Medical today announced a post-market study to evaluate the transcarotid artery revascularization (TCAR) system in the treatment of standard surgical risk patients...
Regional society leaders look forward to VAM and beyond
We asked the presidents of all five major regional vascular societies in the United States for an update on the latest goings-on in their...
Missing something? View VAM 2022 on-demand sessions
Pre-recorded videos from Vascular Annual Meeting (VAM) 2022 sessions are now available on-demand. If videos were submitted by faculty in advance, they will be...
A handy guide for VAM attendees: 2022’s Online Planner
The Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM) 2022 Online Planner is an invaluable companion at the event in Boston's Hynes Convention...
Vascular Live: Variety of vascular concerns on the slate
Be sure to save time for the Vascular Live theater-in-the-round presentations in the Exhibit Hall at the 2022 Vascular Annual Meeting (VAM) in Boston....
SVS special membership sections stage education sessions
For the first time, all those who are part of the five Society for Vascular Surgery (SVS) membership sections have educational presentations geared specifically...
Open repair of infrarenal aortic aneurysm proves preferable to endovascular repair
As part of the Vascular Annual Meeting (VAM) International Fast Talk session on the morning of Wednesday, June 15, Emiliano Chisci, MD, from San...
Discussing ERAS—Enhanced Recovery After Surgery
Enhanced Recovery After Surgery (ERAS) pathways have been beneficial for many surgical specialties and are now available to guide the perioperative care of patients...
Open surgical bypass to distal targets at the ankle is ‘viable’ infrapopliteal CLTI treatment
The Vascular and Endovascular Surgical Society (VESS) Paper Session at the Vascular Annual Meeting (VAM) in Boston on Wednesday, June 15, will see Othman...
Wound healing research earns SVS Foundation prize, place on VAM stage
University of Michigan resident and Vascular Specialist resident/fellow editor Christopher Audu, MD, has been granted the SVS Foundation Resident Research Award for 2022. And,...
Early TCAR results in higher ipsilateral postoperative stroke rates when compared to carotid endarterectomy
Adham Elmously, MD, a fellow at New York Presbyterian Hospital, New York, is set to present outcomes of early transcarotid artery revascularization (TCAR) vs....
‘Endovation’: Guidelines from the front lines
Among the highlights from the “‘Endovation’—Endovascular Innovation for Urgent and Emergency Complex Aortic Disorders” session coming up at the 2022 Vascular Annual Meeting (VAM)...
New data support covered stent use in complex aortoiliac occlusive disease treatment
One-year outcomes from the BELSTREAM trial add to a growing pool of data that covered stents are safe and effective in the treatment of...
The top 10 most popular Vascular Specialist stories in May 2022
News on the Society for Vascular Surgery (SVS) ballots set to determine the next vice president and secretary, a hard-hitting column about vascular surgery's...
Revascularization strategy for BTK intervention should hinge on diagnostic modality, LINC hears
New data provide “another argument” for the use of intravascular ultrasound (IVUS) in below-the-knee (BTK) interventions. This is according to Michael Lichtenberg, MD, from Arnsberg...
SVS has patient resources and guidelines on strokes
May was Stroke Awareness Month, and the Society for Vascular Surgery (SVS) and SVS Foundation offer educational resources for Society members to provide as...
A new pathway for preventing dementia?
Craig Weinkauf, MD, is leading a trial looking into a connection between Alzheimer's and carotid stenosis. ‘We want to try to quantify the brain:...
Register today for two SVS courses
Registration has opened—along with early-bird pricing—for two Society for Vascular Surgery (SVS) in-person courses in coding and reimbursement, and peripheral artery disease (PAD) skills....
Urban or rural: Ensuring access to quality vascular care ‘no matter what’
Michael Dalsing, MD, talks to Vascular Specialist about how his formative years growing up in rural Wisconsin, as well as experience of operating in...
SVS PA Section has new leaders
With previous terms ending, new members have been named to the steering committee for the SVS Physician Assistant Membership Section (PA Section).
Holly Grunebach, PA-C,...
SVS online community adds quality improvement group
The SVS Quality Improvement Committee has created a community on the subject matter on SVSConnect. This will be a forum for QI education and...
Research indicates low stroke risk and benefit of medication alone in asymptomatic carotid stenosis
The risk of having a future stroke caused by asymptomatic carotid stenosis is “so low” that most patients with this condition could potentially be treated with...
75 facts in 75 days to celebrate 75 years
Alton Ochsner, MD, was the first president of the Society for Vascular Surgery (SVS), which was formed in 1946. The first annual meeting—a half-day...
Expanded Medicare coverage for TCAR in standard surgical risk patients announced
Silk Road Medical today announced that the Centers for Medicare and Medicaid Services (CMS), through collaboration with the Society of Vascular Surgery's Patient Safety...
Silent coronary ischemia: FFRCT reduces cardiac death, myocardial infarction in carotid endarterectomy patients out...
Diagnosis of silent, or unsuspected, coronary ischemia in patients undergoing carotid endarterectomy (CEA) using fractional flow reserve-computed tomography (FFRCT), with selective postoperative coronary revascularization,...
The ABS-VSB: Extolling the virtues of vascular surgery’s independent board
The evolutionary process by which vascular surgery became a bona fide independent discipline has much to thank the American Board of Vascular Surgery (ABVS),...
Vascular Specialist–May/June 2022
In this re-launch issue:
The Crawford Forum@VAM 2022: SVS President-elect Michael Dalsing discusses this year's topic: "Quality Vascular Care for All—An Aspirational Goal of...
A modest proposal: Let’s eat the trauma surgeons
Well folks, after more than two years of the pandemic, racial injustice, and medical misinformation, I have decided it is time to return to...
SVS Foundation continues call for VISTA project applicants
The SVS Foundation VISTA (Vascular Volunteers In Service To All) pilot project continues to seek applications for innovative, community-based projects.
The initiative grants support for...
FDA grants IDE approval for Selution SLR drug-eluting balloon
MedAlliance’s Selution SLR drug-eluting balloon (DEB) has received investigational device exemption (IDE) approval from the Food and Drug Administration, making it the first limus...
Medtronic gains FDA nod for IN.PACT 018 DCB
Medtronic has announced approval from the Food and Drug Administration (FDA) for the IN.PACT 018 paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter, a drug-coated...
Register for August Vascular Surgery Board review course
Get ready for the American Board of Surgery Vascular Surgery Board (ABS-VSB) Qualifying Exam in September by attending a comprehensive review course in August.
The...
ESVS publishes 2023 guidelines on management of atherosclerotic carotid and vertebral artery disease
The European Society for Vascular Surgery (ESVS) has just released 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease. The...
VentureMed completes enrollment of Flex Vessel Prep system randomized controlled trial in arteriovenous fistulas
VentureMed Group recently announced that it has completed enrollment of a randomized controlled trial (RCT) entitled "Flex Vessel Prep prior to PTA for the...
Collaborators not cases: Engaging patients with aortic dissections as partners in patient-centered outcomes research
To date, research in aortic dissection has focused on management and outcomes focused on technical results, and survival. Little is known about what is...
Cloud-based fusion imaging found to improve operative metrics during FEVAR
A single-center retrospective review demonstrated a trend towards shorter operative times, and significant reductions in both iodinated contrast use and radiation exposure during fenestrated...
New long-term data of paclitaxel devices continue to show no increased mortality compared to...
New long-term data from the SAFE-PAD (Safety assessment of femoropopliteal endovascular treatment with paclitaxel-coated devices) study were presented today as late-breaking clinical research at...
Shockwave IVL maintains ‘superiority’ to angioplasty in calcified peripheral disease at two years
Shockwave Medical announced today that long-term data from the Disrupt PAD III trial found that superior vessel preparation with intravascular lithotripsy (IVL) led to excellent long-term outcomes...
Tissue samples show paclitaxel effect in minority of CLTI patients receiving DCB angioplasty, study...
Paclitaxel effect was witnessed in tissue specimens of a minority of chronic limb-threatening ischemia (CLTI) patients treated with drug-coated balloons (DCBs)—but was not dependent...
Non-optimal therapy for CLTI ‘more prominent in females’
A real-world claims data analysis of nearly 200,000 patients with chronic limb-threatening ischemia (CLTI) showed that female patients were older, underwent vascular procedures less often, and...
Venovo venous stent returns to US market after 2021 recall
BD recently announced that its Venovo venous stent is back on the U.S. market following a recall last year.
In 2019, the company reported that the...
Cancer patients face greater risks from AAA repair
Elective abdominal aortic aneurysm (AAA) repair in patients with a cancer diagnosis is associated with several poor postoperative outcomes, according to a newly published study from researchers...
75th anniversary: Celebrate SVS history through photos
A week remains in the SVS Photo Contest, which celebrates the Society for Vascular Surgery’s 75th Anniversary. Members are sharing images that tell the...
The top 10 most popular Vascular Specialist stories in April 2022
The digital version of the April 2022 issue of Vascular Specialist, the most recent editorial by our medical editor focusing on diversity within the...
Less frequent post-EVAR surveillance might be safe in some patient groups, study suggests
Results from the multicenter, retrospective ODYSSEUS study carried out in The Netherlands suggest that less frequent surveillance after endovascular aneurysm repair (EVAR) may be...
War in Ukraine: A tale of unspeakable horror, unprecedented unity and unquenchable thirst for...
This editorial was written in the days leading up to April 2.
At about 4 a.m. (Kyiv time) on Feb. 24, Russian President Vladimir Putin...
Artificial intelligence could make endovascular aortic repair outcomes more predictable, CX 2022 hears
At the 2022 Charing Cross (CX) International Symposium (April 26–28) in London, England, Tom Carrell, MD, a vascular surgeon in Cambridge, England, and founder of...
SCAI releases multi-society position statement focused on core competencies for endovascular specialists providing care...
The Society for Cardiovascular Angiography & Interventions (SCAI) has released a position statement outlining competencies for endovascular specialists who provide care for chronic limb-threatening...
Voting for SVS vice president, secretary begins May 23
Society for Vascular Surgery (SVS) Active and Senior members will begin voting May 23 for a new SVS vice president and secretary for 2022–23....
New sirolimus data provide encouragement despite ‘potentially disappointing’ efficacy results
The results of a small-scale pilot study from Asia have indicated “potentially disappointing” results with a novel drug-eluting balloon in treating dysfunctional arteriovenous access...
FDA approves expanded indications for TCAR’s Enroute stent
The Food and Drug Administration (FDA) approved expanded indications for the Enroute stent system—part of the transcarotid artery revascularization (TCAR) procedure—to include patients at...
SVS Foundation seeks applicants for VISTA projects
The SVS Foundation started to seek proposals in mid-April for pilot outreach projects to help identify needed vascular services in underserved portions of the...
CX 2022: IN.PACT AV DCB shows sustained and superior performance compared to PTA through...
New randomized controlled data demonstrating the sustained and superior performance of IN.PACT AV drug-coated balloons (DCBs) compared to percutaneous transluminal angioplasty (PTA) through 36...
SVS turns its sights to FY2023, long-range future
In January, the Society for Vascular Surgery (SVS) Strategic Board met and forged its objectives for the coming fiscal year. Two months later the...
CX 2022: Overtreatment in venous disease: Financial incentives are ‘the elephant in the room’
To combat the “overtreatment problem” in the appropriate care of venous disease, “a concerted, complex, multimodal effort” is required from specialists across disparate parts...
SVS members receive deep discount on key textbooks
Society for Vascular Surgery (SVS) members receive many important discounts as a privilege of belonging. These perks include discounts to important references in diagnosing...
From proposal to podium: Tips for getting your abstract accepted at academic conferences
Striving for excellence in research is one of the defining characteristics of an academic surgeon. But simply doing great research is not enough. The...
Veteran community care: Ensuring community care plays a vital role within the VA health...
Concerns about veterans getting access to quality healthcare in a timely fashion led to the Veterans Choice Act in 2014 followed by the VA...
VAM packed from beginning to end
From the opening session on the Wednesday morning of the Vascular Annual Meeting (VAM), to announcing the winners of the Poster Competition Championship Round...
Rockman: A family story of self-identity
Outgoing Society for Vascular Surgery (SCVS) President Caron Rockman, MD, delved into her family history from late-19th century and early- 20th century Russia to...
VAM: Gala auctions taking shape
It's spring now, but those whose winters seem never-ending might consider bidding on a week-long stay in Florida for next winter. Cold and snow...
Terumo Aortic announces FDA approval for Thoraflex Hybrid frozen elephant trunk device
Terumo Aortic today announced that the Food and Drug Administration (FDA) has granted approval of the Thoraflex Hybrid frozen elephant trunk device for commercial...
SCAI issues position paper on transaxillary arterial access
The Society for Cardiovascular Angiography & Interventions (SCAI) has released an official position statement providing evidence-based recommendations for percutaneous transaxillary arterial access and training...
The top 10 most popular Vascular Specialist stories in March
Among the posts catching Vascular Specialist readers' eyes last month were the digital flipbook version of our March print edition, a new study looking...
Supply & demand: [Private] practice matters
Vascular surgeons in private practice could play a crucial role in alleviating one of the existential problems currently vexing the specialty: The training of...
Cydar Medical announces strategic collaboration with Medtronic
Cydar Medical recently announced it has entered a strategic collaboration with Medtronic. Under the pilot arrangement, Cydar’s EV Maps software will be introduced to up...
Our past is prologue: We are losing the battle to train more Black doctors
My mother was a child of the 1960s. Despite not having a college degree, she was determined to teach my sister and me that...
Alucent Biomedical announces first patient enrolled in first-in-human natural vascular scaffolding clinical trial
Alucent Biomedical announced in a press release that it has enrolled the first patient in ACTIVATE II, an Australia-based first-in-human clinical trial to evaluate the...
Help tell the SVS story through images
Thanks to smartphones, almost everyone usually has a good camera at hand and thousands of digital photos in storage.
So get that phone charged and be...
Interview: SCVS leaders discuss training challenges, position of private practice, diversifying generation of surgeons
Barriers thrown up between the worlds of private or community vascular surgery and academic practice need to be dismantled for the betterment of the...
Vascular Specialist–April 2022
In this issue:
In our April cover story, we report from the Society for Clinical Vascular Surgery (SCVS) Annual Symposium on new evidence that...
At VRIC 2022, Clowes lecturer to walk in research footsteps of field progenitor
When Kathleen Martin, PhD, gives the Alexander W. Clowes Distinguished Lecture at the 2022 Vascular Research Initiatives Conference (VRIC) in May, she’ll be discussing...
Rare case series shows 100% limb salvage in pediatric bone tumor resections with vascular...
A retrospective review of a rare set of pediatric bone tumor resection cases with significant blood vessel involvement has demonstrated 100% limb salvage and...
Interview: JVS group enters new era with brand chief and team-based approach
With changes occurring regularly in the publication business of scientific journals, the Society for Vascular Surgery (SVS) is planning changes with its own Journal...
VAM: How abstracts are selected
The abstracts presented at the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM) are the result not just of thorough research, but also...
SVS’ AMA membership push aimed at safeguarding vascular surgery voice on coding issues
The Society for Vascular Surgery (SVS) is urging members to join the American Medical Association (AMA) in a bid to maintain a critical voice...
Shockwave Medical announces global launch of new peripheral IVL catheter
Shockwave Medical has announced the global commercial availability of the Shockwave M5+ peripheral intravascular lithotripsy (IVL) catheter after receiving both Food and Drug Administration (FDA) and...
Cook Medical receives FDA Breakthrough Device designation for Zenith Thoraco+ endovascular system
Cook Medical’s Zenith Thoraco+ endovascular system (Thoraco+) has received Breakthrough Device designation from the Food and Drug Administration (FDA), a press release reports.
The company...
Medtronic issues voluntary recall for subset of IN.PACT Admiral and IN.PACT AV DCBs
Medtronic recently voluntarily recalled a subset of its IN.PACT Admiral and IN.PACT AV paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheters due to the potential...
Select gene SNPs found to be associated with venous ulcer formation and persistence
Looking to the future, genetic testing may play a role in guiding the intensity of therapeutic interventions and preventive strategies in patients with venous...
SCVS 2022: WIfI score does not predict successful healing after transmetatarsal amputation, study finds
A higher initial Wound, ischemia, and foot infection (WIfI) classification score at initial presentation in chronic limb-threatening ischemia (CLTI) patients who underwent a transmetatarsal...
Randomized trial suggests carotid endarterectomy does not affect dementia risk
Carotid endarterectomy (CEA) does not appear to either reduce or increase the risk of dementia, despite it having been shown to reduce stroke risk....
Increased market competition linked to higher odds of revascularization among asymptomatic patients with moderate...
A vascular surgery research team with a growing reputation for its work investigating appropriateness in care in the peripheral vascular bed recently uncovered an...
Medical students reach out to hemodialysis community in times of COVID-19
As president of the Louisiana State University (LSU) Vascular Surgery Interest Group (VSIG), I’ve been eagerly exploring opportunities to engage with community members and...
Nominations due March 31 for community practice award
Nominations for the Society for Vascular Surgery‘s prestigious Excellence in Community Practice Award are due March 31.
The honor, formerly known as the Excellence in...
Peer-reviewed COVID-19 archive grows
Two years in, an indicator of COVID-19’s continuing presence in the world is the growth of the “COVID-19 Collection” in the pages of the...
Diabetes: Impact of local medicolegal landscapes on costs
More litigious U.S. states did not see decreased amputation rates over those where the medicolegal environment was less adverse, according to an analysis of...
SCVS 2022: ‘We should not allow our industry relationships influence how we choose to...
Industry players and device makers have helped spark new science and innovation in vascular surgery amid flatlining National Institutes of Health (NIH) funding, but...
Apply for health policy program by March 25
Applications are due by 11:59 p.m. Central Standard Time on March 25 for the joint American College of Surgeons/Society for Vascular Surgery scholarship to...
Vascular Surgery Board seeks director nominees
The Vascular Surgery Board (VSB) of the American Board of Surgery (ABS) is seeking director nominees to serve a six-year term beginning July 1,...
Potential ‘new paradigm’ in treatment of long occlusive lesions emerges
Vascular surgeon Lewis Schwartz, MD, has had an interest in biomedical engineering since very early in his career. So his involvement in the early-stage...
Moments suspended in time: Joining the vascular fold
Noon on March 19, 2021, marked the end of an unprecedented year in the world of resident recruiting. Months of virtual interviews, “away” rotations...
SVS creates membership section for women
Women make up a growing percentage of vascular surgeons. And they now have a new professional membership home within the Society for Vascular Surgery...
Boston calling: Registration for VAM 2022 is open
Registration and housing for the Society for Vascular Surgery (SVS) 2022 Vascular Annual Meeting (VAM) are now open. This year’s premiere educational event for...
Database analysis findings ‘matched precisely’ with reported reasons for venous stent recalls
A recent analysis recalled Venovo and Vici venous stents—initiated last year—characterized “significant differences” between reported device and patient issues, and subsequent interventions for the...
The pandemic has been a challenge, but perhaps it imposed some equity
Years from now when we look back, will we measure time in terms of B.C. and A.C.—Before Covid and After Covid? It’s hard to...
Life of Achilles: Turning weakness into bursts of innovation, creativity
Themes rooted in the life of Achilles, the heroic figure from Greek mythology, and the concept of “emotional stamina” underpinned the message delivered from...
F/BEVAR review reveals less than 20% of patients suffered intraoperative adverse event
A retrospective evaluation of 600 fenestrated or branched endovascular aneurysm repairs (F/BEVARs) for the treatment of complex aneurysms revealed that fewer than one in...
Biomarkers of heart failure show early reversal with catheter thrombolysis compared to anticoagulation alone...
In a secondary analysis of the SUNSET sPE randomized control trial, lead investigator Efthymios Avgerinos, MD, of the division of vascular surgery, University of...
Dedicated vs. non-dedicated: Researchers place venous stenting under the spotlight at AVF 2022
Venous stenting was a hot topic on the agenda of the recent American Venous Forum (AVF) annual meeting, held this year Feb. 23–26 in Orlando,...
PROMISE II U.S. pivotal trial of device designed for ‘no-option’ CLTI patients completes enrollment
Enrollment has been completed in the PROMISE II pivotal trial of the LimFlow deep vein arterialization system designed to prevent amputations in so-called "no-option"...
Viabahn use in claudicants with long, complex SFA lesions ‘safe and effective’ through five...
Recently published research indicates that stent grafting with the Viabahn endoprosthesis (W L Gore & Associates) of long and complex superficial femoral artery (SFA) lesions in...
The top 10 most popular Vascular Specialist stories in February
February's top 10 includes a highlight from the 2022 Vascular and Endovascular Surgery Society (VESS) winter annual meeting and an interview with Melissa Kirkwood,...
Lesson learned: Entering vascular residency during first wave of pandemic
An insight into the benefits of virtual learning from the perspective of a medical student on the cusp of residency as the early stages...
Vascular Specialist–March 2022
In this issue:
Dedicated vs. non-dedicated: Researchers place venous stenting under the spotlight at the American Venous Forum (AVF) 2022 annual meeting (p. 1 and...
New JVS editorial leadership structure announced
The Executive Board of the Society for Vascular Surgery (SVS) recently revealed the new composition of the Journal of Vascular Surgery (JVS) publications‘ senior...
Writing and reviewing in the DEI space: Progress evident but ‘there’s a lot of...
It’s been more than 18 months since the Journal of Vascular Surgery (JVS) implemented changes aimed in part at diversifying involvement with the publication...
Venous stents remain durable following pregnancy, researchers find
Iliac vein stents tolerate a gravid uterus well and a possible future pregnancy should not contraindicate their usage in the treatment of pelvic venous...
Houston, we have a dialysis access problem
The concept of dedicated vascular access centers fuels a turbocharged Texan tussle with Karl Illig, MD, of Flow Vascular Institute in Houston, taking on Eric...
VAM 2022 will offer innovative formats
The Society for Vascular Surgery (SVS) Postgraduate Education Committee is breaking up the format in favor of change and innovation for two sessions at...
AVF 2022: Emerging autogenous venous valve formation system sees ‘continual improvement’
An emerging endovenous valve formation system designed to treat patients with chronic venous insufficiency (CVI) with evidence of deep venous reflux has demonstrated continual...
FDA advisory panel issues recommendations on lifelong surveillance for EVAR
The Food and Drug Administration (FDA) recently announced it has issued a letter to healthcare providers emphasizing the importance of lifelong surveillance, including imaging,...
Time’s nearly up: Apply for VAM travel scholarships by March 9
Time is quickly running out for medical students and general surgery residents to apply for Society for Vascular Surgery (SVS) travel scholarships to attend...
Tickets selling briskly for Gala: ‘Cheers to 75 Years’
More than 330 people have registered their intentions to raise a glass to toast the Society for Vascular Surgery's quarter-century of helping vascular patients...
AVF 2022: Six-month CLOUT data indicate ClotTriever can effectively remove full spectrum of thrombus
Six-month outcomes from the ongoing CLOUT registry demonstrate the “safety and efficacy” of the ClotTriever thrombectomy system in a real-world deep vein thrombosis (DVT)...
AVF 2022: VenoValve improvement ‘maintained’ for 2.5 years without adverse events
Envveno Medical announced positive 30-month data from the first-in-human trial of the VenoValve bioprosthetic potential venous valve replacement during the 2022 American Venous Forum (AVF)...
VAM 2022: More science, discussion, streaming
With abstract selection finished this month and the lineup of many other sessions in place, organizers are excited about the offerings of the 2022...
Sex discordance and postoperative outcomes: We should be vigilant of a real disparity in...
The recent JAMA Surgery publication “Association of surgeon-patient sex concordance with postoperative outcomes” is a population-based, retrospective cohort study of more than 1 million...
Study ‘supports’ SVS open AAA volume recommendations
A multicenter, retrospective database analysis suggests improved open abdominal aortic aneurysm (AAA) outcomes when surgeon volume is greater than seven cases yearly and performed in...
Perioperative care in open aortic surgery: SVS and ERAS Society issue consensus statement
The Society for Vascular Surgery (SVS) and the Stockholm, Sweden-based Enhanced Recovery after Surgery (ERAS) Society have released a consensus statement intended to help...
‘Cheers to 75 Years’: Anniversary Gala tickets go on sale on Feb. 22
How will you help the Society for Vascular Surgery (SVS) celebrate “Cheers to 75 Years?”
Maybe it's offering an adventure in the wilderness, on a...
Ra Medical Systems receives FDA approval for increased enrollment in atherectomy clinical trial
Ra Medical Systems, a medical device company focused on developing the excimer laser system to treat vascular diseases, has announced that enrollment has reached...
SVS PAC: A voice for vascular surgeons on Capitol Hill
As everyone turned the page on 2021 and entered 2022 with a new hope for a return to normalcy, vascular surgeons continue to be...
VRIC input in 2021 helped strengthen research, says award-winner
The Society for Vascular Surgery (SVS) Vascular Research Initiatives Conference (VRIC) in 2021 helped Sriganesh (Sri) Sharma, MD, better understand his own work.
During the...
Diversity efforts while in training: Is it just another box to check?
2020 was a herald year. It ushered in a global pandemic and a reckoning with issues of diversity, equity and inclusion (DEI) in our...
Community practice award deadline extended
There's still time! The Society for Vascular Surgery (SVS) has extended the deadline to nominate an SVS member for the prestigious Excellence in Community...
From the SVS journals
The Journal of Vascular Surgery Cases, Innovations and Techniques has been growing rapidly, publishing an estimated 33% more articles this year than two years...
Silence is golden—but does self-imposed silence lead to burnout?
Burnout is associated with silence in various contexts. It is called the silent crisis, the silent epidemic, or the silent killer. What is not...
First patient enrolled in PEERLESS study of FlowTriever system
Inari Medical has announced that the first patient has been enrolled in PEERLESS prospective, randomized controlled trial (RCT) comparing the outcomes of patients with...
New data add to body of evidence highlighting ‘importance’ of vascular surgery in trauma...
Another study has emerged showing vascular surgery’s heavy intraoperative consult activity in a level 1 trauma center setting, lending further fuel to the “vascular...
Complex TAAA: US ARC IDE registry reports better survival vs. real-world data after endovascular...
Patients treated in Food and Drug Administration (FDA)-approved investigational device exemption (IDE) trials for complex thoracoabdominal aortic aneurysms (TAAAs) in the U.S. Aortic...
Apply for VAM travel scholarships by March 9
Medical students and general surgery residents have until March 9 to apply for Society for Vascular Surgery (SVS) travel scholarships that enable attendance at...
March 1 awards deadline nears
The deadline is March 1 for several awards and honors from the Society for Vascular Surgery (SVS) and the SVS Foundation. They include the...
Vascular Specialist–February 2022
In this issue:
"Vital signs": Reporting from the Southern Association for Vascular Surgery (SAVS) annual meeting on skyrocketing nursing costs and their contribution to...
Worldwide TCAR analysis provides ‘roadmap’ to evaluate future training approaches
An analysis of the worldwide experience of transcarotid artery revascularization (TCAR) has produced key objective proficiency metrics and an analytic framework to assess adequate...
Study highlights need to extend scope of cerebrovascular health disparities research
A new research letter in Stroke outlines use of the novel National Institutes of Health (NIH) All of Us research program dataset of diverse...
The top 10 most popular Vascular Specialist stories in January
January’s top 10 includes “Our forever plague,” a combined editorial by Malachi Sheahan III, MD, our medical editor, on fake news and science, and...
Medtronic issues voluntary recall for TurboHawk Plus directional atherectomy system
On Feb. 7, Medtronic issued a notice emphasizing that the same warnings and precautions issued for the HawkOne directional atherectomy system also apply for...
Index atherectomy interventions for claudication ‘is associated with higher’ reintervention rates vs. other technologies
Atherectomy use during index peripheral vascular interventions in claudicants is associated with higher reintervention rates when compared to other technologies, a newly unveiled study...
Marston: Diversity required to deliver comprehensive care to vascular disease population
William A. Marston, MD, was recalling a recent experience acting as a bone marrow donor for a family member, and the moment it dawned...
Interview: Combating the problem of spin, or overinterpretation, in RCTs
The presence of spin, or overinterpretation, in scientific papers that ultimately demonstrate statistically insignificant findings had been gnawing away at Thomas Forbes, MD, for...
Risk of venous stent migration ‘rare’ but probably ‘underreported,’ systematic review finds
Stent migration following treatment of acute iliofemoral thrombus or venous obstruction is “rare but may be underreported,” with the majority of reported cases being...
Radiation protection: Lightweight shield designed to reduce dose during complex endovascular procedures gains ground
It all started with a “we should do research together; this is fascinating.” The result—the production of a prototype eyewear that decreases radiation to...
VESS 2022: Novel use of TCAR to treat complex brachiocephalic disease shown to be...
A "unique" case series of patients undergoing transcarotid artery revascularization (TCAR) in which the system was put to novel use for proximal intervention or...
Office-based laboratory setting proves ‘safe’ for iliac vein stenting
A retrospective study of 1,223 iliac vein cases performed in three office-based laboratories (OBLs) demonstrated a major complication rate of 0.41%, suggesting these procedures...
FDA issues guidance documents for including patient perspectives in medical device studies
The Food and Drug Administration (FDA) has issued two final guidances providing recommendations for including patient perspectives in medical device clinical studies.
As per...
WFVS seeks to help shape future of global vascular training through technology and collaboration
The World Federation of Vascular Societies (WFVS) recently entered a new era of governance with the aim of better disseminating science and best practices...
Study suggests more proximal landing zone is preferred for TEVAR of acute type B...
A review evaluating the results of thoracic endovascular aortic repair (TEVAR) following acute type B aortic dissection suggests most patients have less than 2cm...
Conveying vascular surgery’s essential ‘coolness’
Let’s start with a question: how do we communicate coolness? No, I am not referring to a cool or cold foot in the emergency...
Priorities and objectives will guide 2022 SVS programs
Whether it’s branding, advocacy or determining research initiatives, the process of setting Society for Vascular Surgery (SVS) priorities and objectives begins with SVS members....
Strength in numbers: Global VASCC COVID-19 project helps identify framework to tackle delayed cases
When Robert Cuff, MD, and Max Wohlauer, MD, first launched the Vascular Surgery COVID-19 Collaborative (VASCC) back in the spring of 2020, the pandemic...
Guidelines recognize potential role for earlier endovascular treatment of uncomplicated type B aortic dissection
New clinical practice guidelines published today aim to act as “guard rails” to determine the treatment options and best practices for managing patients with...
UPDATED: Last call for community practice accolade
The clock is ticking to submit nominations for the 2022 Society for Vascular Surgery (SVS) Excellence in Community Practice Award—with an extended deadline now...
Cook Medical receives FDA breakthrough designation for new drug-eluting stent
Cook Medical has received Breakthrough Device designation from the Food and Drug Administration (FDA) on a new drug-eluting stent (DES) for below the knee...
SAVS 2022: ‘Recruiting more women without knowing race/ethnicity of those women only tells part...
Failure to stratify gender by race or ethnicity, or vice versa, leads to missed opportunities in the recruitment of underrepresented members from the potential...
Medtronic recalls HawkOne directional atherectomy system
Medtronic has recalled 95,110 HawkOne directional atherectomy system devices distributed in the United States between Jan. 22, 2018, and Oct. 4, 2021, the Food...
SVS to hold Surgical Coaching Program webinar Jan. 24
Professional athletes and musicians have coaches to help them “up their games.” It follows then that vascular surgeons can benefit from coaching within the...
SAVS 2022: Skyrocketing vascular nursing costs hammer division’s financial bottom line
The profit margin of a vascular surgery division at a prominent health system in New Orleans was severely eroded during the COVID-19 pandemic period—despite...
A balance is required with non-compete agreements in surgical practice
Unless prohibited by state law, most physicians employed by hospitals or physician groups are required to sign non-compete agreements (NCAs). A recent survey of...
Giving November initiative brings in $50,000-plus to SVS Foundation
The SVS Foundation’s extension of Giving Today into Giving November was a big success, with more than $50,000 donated to Foundation research, grants, awards...
Thrombolex: Investigational RESCUE trial yields ‘exciting’ interim data
The prespecified interim analysis of the first 62 evaluable pulmonary embolism (PE) patients enrolled in the investigational RESCUE trial produced positive results, Thrombolex has...
Live-streaming to return at VAM 2022
After a successful debut in 2021, live-streaming of a variety of sessions will return to the Society for Vascular Surgery (SVS) Vascular Annual Meeting...
Formally introducing Christopher Audu
The team at Vascular Specialist—led by Malachi Sheahan III, MD—is pleased to announce the appointment of University of Michigan resident Christopher Audu, MD, as...
Corner Stitch: From intentions to gratitude in 2022
A time of transition, like the dawn of a New Year, usually commences the mass drive for New Year’s resolutions and intentions. Many of...
Members involved in suggesting topics for VAM 2022 sessions
Society for Vascular Surgery (SVS) program planners are finalizing the lineup and topics for several types of educational session for the 2022 Vascular Annual...
Philips integrates cloud-based AI and 3D mapping into its mobile C-arm system series
Royal Philips has announced physicians will now have access to advanced new 3D image guidance capabilities through its image-guided therapy mobile C-arm system—Zenition. The...
VA: Cutting through the ‘red tape’ of research
Creating an academic career with a perfect blend of clinical work and protected time for productive research is a struggle for many surgeon-scientists. Many...
ISET 2022 audience hears latest data on endovascular therapies
At this year’s International Symposium on Endovascular Therapy (ISET), being held Jan. 16–19 in Hollywood, Florida, experts presented an array of late-breaking trial results...
Powell: Studies linking EVAR and cancer risk continue to mount
Evidence continues to accumulate of a link between endovascular aneurysm repair (EVAR) and cancer, with even small amounts of radiation potentially converting epithelial cells...
Vascular Specialist–January 2022
In this issue:
"Strength in numbers": Global VASCC COVID-19 registries have already helped identify a framework to tackle delayed cases with applicability both inside...
CSI announces development of IVL technology for the treatment of PAD
Cardiovascular Systems (CSI) recently announced that it has made significant progress towards the commercialization of its intravascular lithotripsy (IVL) system for the treatment of...
Europe: ESVS publishes 2022 guidelines on management of chronic venous disease of the lower...
The European Society for Vascular Surgery (ESVS) has released 2022 clinical practice guidelines on the management of chronic venous disease (CVD) of the lower...
New recommendations promote ‘appropriate and effective’ use of social media in medicine
In response to a rapid augmentation of social media use in medicine over the past five years, the Society for Vascular Surgery (SVS) has...
US IDE Aortic Research Consortium ‘pushes the envelope’ on F/BEVAR
The U.S. investigational device exemption (IDE) Aortic Research Consortium has produced the strongest data so far on the use of fenestrated/branched endovascular aneurysm repair...
Our forever plague
The following is a combined and revised version of the November and December 2021 editorials on fake news and science denial published in Vascular...
Deadlines near for slew of awards, honors
It’s awards season at the Society for Vascular Surgery (SVS) and the SVS Foundation, with deadlines in January, February and March for many awards...
FDA issues updated safety communication on use of Endologix AFX endovascular grafts
The Food and Drug Administration (FDA) has issued an updated safety communication on the use of Endologix AFX endovascular grafts. This update includes...
VAM travel scholarship applications available this month
Medical students and general surgery residents will be able to apply this month for travel scholarships to attend the 2022 Society for Vascular Surgery...
SVS PAD course postponed
The new Society for Vascular Surgery (SVS) Peripheral Arterial Disease (PAD) Skills Course has been postponed amid the COVID-19 pandemic recent surge in cases,...
Deadlines near to submit VRIC and VAM abstracts
Abstract submissions for possible presentation at the 2022 Vascular Research Initiatives Conference (VRIC) and the 2022 Vascular Annual Meeting (VAM) in Boston are due...
VIVID study on Duo venous stent system now fully enrolled, Vesper Medical announces
Vesper Medical recently announced the completion of enrollment in its pivotal study—VIVID (Venous stent for the iliofemoral vein investigational clinical trial using the Vesper Duo venous stent...
‘Meet the Experts’ webinars now available OnDemand
Society for Vascular Surgery (SVS) members now have another chance to “Meet the Experts,” via computer screen and at no charge.
Three of the...
VESS: A society primed for young vascular surgeons, trainees and medical students
Welcome to December where the calendar is filled with abstract and registration deadlines to various meetings through the summer of 2022. In this month‘s...
FDA approves two pediatric venous thromboembolism indications for rivaroxaban
The Food and Drug Administration (FDA) has approved two pediatric indications for Xarelto (rivaroxaban): the treatment of venous thromboembolism (VTE) and reduction in the risk of recurrent...
CLI at a crossroads: Which direction now?
Vascular surgery once again finds itself at a crossroads, Michael Belkin, MD, chief of the division of vascular and endovascular surgery at Brigham and...
Nominate ‘giver, doer’ for Excellence in Community Service Award
The Society for Vascular Surgery (SVS) is asking members to consider who among the many excellent vascular surgeons they may know in community practice...
Explaining the No Surprises Act
The vast scope of the No Surprises Act—legislation signed into law in late 2020—may mean some Society for Vascular Surgery (SVS) members are not...
‘Leveraging multiple teams and cardiovascular specialists’
This quarter’s Leadership Corner features Young Erben, MD, interviewing Charles B. Ross, MD, chief of vascular and endovascular services at Piedmont Heart Institute, Piedmont...
TCAR affords greater quality-adjusted life years than carotid endarterectomy, cost-effectiveness model finds
A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR) were higher than those for carotid endarterectomy (CEA), TCAR afforded...
SVS issues new guidelines covering carotid disease and popliteal aneurysms
The Society for Vascular Surgery (SVS) has released updated clinical practice guidelines for the management of extracranial cerebrovascular disease and popliteal artery aneurysms in...
Task Force to address question: How will we care for pediatric vascular patients?
Along with the American Pediatric Surgical Association (APSA), the Society for Vascular Surgery (SVS) plans to minimize and close some very real gaps in...
In paying back, Joe Hart pays it forward
For Joe Hart, MD, a larger donation to the Society for Vascular Surgery (SVS) Foundation this past year is helping him pay back several...
Wei Zhou: Prepared for change—and a more diverse, vocal generation of surgeons
There was something of a different pulse to some of the matters around this year’s Western Vascular Society (WVS) annual meeting, recalls Wei Zhou,...
Venous disease: SVS DEI Committee seeks survey participants
The Society for Vascular Surgery (SVS) Diversity, Equity and Inclusion (DEI) Committee is calling on vascular surgeons to complete a survey focused on patterns...
Planning underway for next VAM
One of the innovations—livestreaming— introduced at the 2021 Vascular Annual Meeting (VAM), is influencing the 2022 schedule.
“The streaming option, particularly for international members,...
Collaborative effort key to investigating potential biomarker of acute aortic syndrome
Research indicates that plasma desmosine has the potential to act as a biomarker of acute aortic syndrome and could, in the future, be used as a...
VRIC 2022 to be held May 11 in Seattle
The Society for Vascular Surgery’s 2022 Vascular Research Initiatives Conference (VRIC) will return to its spring timeframe of the past several years.
Abstract submission...
Smoking status ‘should not deter nor delay’ endovascular intervention in femoropopliteal vessels
Smoking does not seem to affect reocclusion rates, interval to reintervention and the total number of interventions in peripheral arterial disease (PAD) patients with...
Surgeons must stay skilled in femorotibial/pedal bypass surgery, Paris audience hears
At Paris Vascular Insights (PVI) 2021 (Oct. 21–23, Paris, France), Peter Schneider, MD, University of California San Francisco, San Francisco, emphasized the need for...
PTFE crural bypasses: ‘Very acceptable patency, excellent limb salvage is obtainable with a fairly...
“The mantra I always use with fellows is bad vein, bad bypass.” Those were the words of Gregg Landis, MD, system chief of vascular...
Senate passes bill to halt 2022 Medicare cuts
Last night, the Senate passed legislation to halt Medicare physician payment cuts that were scheduled to take effect on January 1. President Joe Biden...
New attending call model aimed at fatigue mitigation produces ‘stable’ workflow
A “paradigm shift” in attending call staffing with a focus on fatigue mitigation can be undertaken in a vascular surgery practice without disruption to...
Amplifi vein dilation system demonstrates ‘encouraging’ clinical results in hemodialysis access
Artio Medical announced that full results from its first-in-human clinical study of the Amplifi vein dilation system were presented at the 2021 VEITHSymposium (Nov....
Review the year in SVS Foundation annual report
In a year prominently defined once more by COVID-19, the SVS Foundation nonetheless took some big steps forward, with new initiatives and a big...
VSIGs increase early exposure to vascular surgery in med school
This month, we are focusing on medical student recruitment into vascular surgery. In many medical schools, students do not get any exposure to the...
Canadian Vascular: Spin in RCTs
A large proportion of statistically nonsignificant randomized controlled trials (RCTs) yielded interpretations that were inconsistent with their results, according to an analysis of 31...
Learn by doing at February SVS PAD workshop
The Society for Vascular Surgery (SVS) Peripheral Arterial Disease (PAD) Workshop in February will feature four hours of hands-on surgical skills training, on 10...
New ACS president aims to sow seeds of hope for enhanced recovery amid pandemic
Former Society for Vascular Surgery (SVS) President Julie A. Freischlag recently took over the presidential reins of the American College of Surgeons (ACS). Here...
Rise in cardiovascular disease, vascular surgeon burnout presents a public health crisis, Western Vascular...
Cases of cardiovascular disease are rising across the U.S., with large disparities seen in ethnic groups and poorer geographical areas. In combination with increased...
Re-emerging from the pandemic: ‘What truly motivates us?’
How to find “flow” and motivation through goal setting, and reacquainting with “intrinsic priorities” on the other side of the COVID-19 pandemic, formed the...
Clinical evaluation of robotic-assisted peripheral artery intervention in human completed
Aopeng Medical’s Allvas endovascular intervention surgical robot has successfully carried out a first-in-human clinical evaluation of a robot-assisted peripheral artery intervention of an iliac...
Open repair: In good hands?
The twin issues of center volumes for open AAA repair as well as training implications came under the spotlight at two recent regional vascular...
‘Female sex predicts reintervention after elective EVAR for AAA’
Females were found to be at greater risk of reintervention following elective endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) at both the...
We need voices as well as opinions
I have a message for my colleagues on behalf of Society for Vascular Surgery (SVS) Political Action Committee (PAC), quoting the famous lines from...
Journey of a trainee surgeon-scientist: Mentorship, passion and the importance of parallel projects
In August, University of Michigan general surgery resident W. James Melvin, MD, picked up the coveted Society for Vascular Surgery (SVS) Foundation Resident Research...
Endologix announces completion of enrollment in TORUS 2 study for PAD in SFA
Endologix has completed enrollment in the TORUS 2 investigational device exemption (IDE) clinical study in the U.S., a press release reports.
The TORUS 2 study...
Prediabetes screening: ‘Target of reducing disparities should be geared towards advocacy’
On Aug. 24, the United States Preventive Services Task Force (USPSTF) published the newly updated recommendations regarding screening for prediabetes and type-2 diabetes mellitus.1,2...
First patient enrolled in Disrupt BTK II study for long, calcified, below-the-knee lesions
Shockwave Medical has announced the start of the Disrupt BTK II postmarket study to assess the safety, effectiveness and optimal clinical use of the Shockwave...
Research reveals improved outcomes, decreased mortality in management of aortic dissections with multidisciplinary care...
The Minneapolis Heart Institute Foundation (MHIF) has announced the publication of research showing improved patient outcomes and significantly decreased 30-day mortality in aortic dissection patients...
Intraoperative vascular consults have risen 529% in last 15 years, single-center analysis finds
According to researchers from the University of Washington level 1 trauma center, the number of intraoperative vascular surgeon consultations has increased enormously over the...
Study: Early thrombosis after iliac stenting for venous outflow occlusion is related to disease...
Fewer than 10 days of low-molecular-weight heparin (LMWH) after stenting for extensive iliofemoral venous occlusion prior to transition to oral anticoagulation reduces early thrombosis,...
VEITH 2021: Researchers present ex vivo demonstration of fluoroscopy-free complex AAA stent placement
“I think this represents the beginning of the end of an era where we have to use lead to perform these procedures.” Those were...
VEITH 2021: Two-year follow-up data from EVAS2 IDE study delivered
The confirmatory EVAS2 clinical study to evaluate the safety and effectiveness of Endologix's Nellix endovascular aneurysm sealing system (EVAS) for the treatment of infrarenal...
Viz.ai reveals launch of new AI-powered modules for pulmonary embolism, aortic disease
Viz.ai—a company focused on artificial intelligence (AI)-driven intelligent care coordination—today announced the U.S. commercial launch of its AI-powered modules for pulmonary embolism (PE) and...
Interview: The value and utility of surgical sketches
W. Michael Park, MD, was first turned onto the utility and wonder of anatomical sketching during medical school. Back then, he developed an affinity...
Vascular Specialist–November 2021
In this issue:
"In good hands?" The twin issues of center volumes for open AAA repair as well as training implications came under the...
IN.PACT Admiral DCB performs well across wide range of clinical, anatomical scenarios in pooled...
In a pooled analysis of the predictors of drug-coated balloon (DCB) effectiveness, the IN.PACT Admiral DCB (Medtronic) performed well across a broad range of clinical, anatomical...
Take advantage of SVS diabetes resources
November is National Diabetes Month. The Society for Vascular Surgery (SVS) has many resources to help its members educate their patients and families and...
Hispanic adults with PAD access inpatient care most often via the emergency room
Hispanic adults hospitalized for treatment of symptoms of peripheral arterial disease (PAD) were more likely to access this care by going to the emergency...
Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data
The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term...
Philips announces large-scale study outcomes on use of IVUS in peripheral interventions
Royal Philips has announced the results of a new large-scale real-world analysis of Centers for Medicare & Medicaid Services (CMS) data on the health...
VQI launches fellowship in training program, announces scholarship
The Society for Vascular Surgery’s Vascular Quality Initiative (SVS VQI) is launching a new SVS Patient Safety Organization VQI Fellowship in Training (SVS PSO...
Trainee wellness: ‘No one really prepared me for the failures’
Communication and an awareness of how often vascular surgery fails emerged as key talking points during a Vascular Surgery Interest Group (VSIG) Lunch Symposium...
SVS: Impact of Medicare Physician Fee Schedule final rule remains threat to patient care
The Medicare Physician Fee Schedule (MPFS) final rule released Nov. 2 by the Centers for Medicare & Medicaid Services (CMS) doubles down on the...
Researchers develop ‘world’s first’ smart bandage that detects multiple biomarkers for chronic wound monitoring
A research team led by Lim Chwee Teck, PhD, from the National University of Singapore’s (NUS) Department of Biomedical Engineering and Institute for Health...
Learn best-, worst-case and likely scenarios of upcoming planned cuts to Medicare
The Society for Vascular Surgery (SVS) will hold a Town Hall Nov. 10 to help members understand the upcoming planned federal cuts that would...
Six top tips to help navigate interview season
Ahh October… The air is a bit cooler; pumpkin spice is in everything; and leaf colors are more dazzling. It’s interview season! If you’re...
Ontario registry risk model provides ‘reliable’ predictions of stroke, death following carotid endarterectomy
The Ontario carotid endarterectomy registry (OCER) model was found to be the most reliable predictor of stroke or death after carotid endarterectomy (CEA) among...
Julie A. Freischlag becomes president of American College of Surgeons
Newly installed American College of Surgeons (ACS) President Julie A. Freischlag, MD, called for her fellow surgeons to apply the principles that underpin enhanced...
Re-visit VAM: Watch sessions you missed
Registrants for the 2021 Vascular Annual Meeting (VAM) can now catch sessions they may have missed in San Diego—or otherwise review a critical presentation...
SVS Foundation seeks auction items for VAM 2022 Gala
The SVS Foundation is planning what promises to be 2022’s party of the year—and needs the help of Society for Vascular Surgery (SVS) members....
Envveno Medical reports successful completion of first VenoValve surgery in US pivotal trial
Envveno Medical—formerly Hancock Jaffe Laboratories—recently announced that the first VenoValve surgery in the company’s SAVVE US pivotal trial for the VenoValve has been successfully...
WIfI system helps predict revascularization benefit for diabetic patients with CLTI, study finds
A retrospective study supports the use of the Wound, ischemia, and foot infection (WIfI) classification system to predict the revascularization benefit for diabetic patients with chronic limb-threatening ischemia...
Our broken system: Medical liability in vascular practice
My last editorial, “How to succeed in vascular surgery: A guide for the aspiring outlier,” was more controversial than I expected. I naively believed...
Sanford invents Breakthrough Device for TAAA
An investigational device invented at Sanford Health in Sioux Falls, South Dakota, that helps high-risk vascular disease patients has been granted a Breakthrough Device...
Julie A. Freischlag to be installed as ACS president
Former Society for Vascular Surgery (SVS) President Julie A. Freischlag, MD, will be installed as the 2021-22 president of the American College of Surgeons...
WVS 2021: Western Vascular Society names new president-elect
University of Southern California (USC) vascular chief Vincent Rowe, MD, took over as the new president of the Western Vascular Society (WVS)—with University of...
WVS 2021: Community surgeons report improved rAAA survival after adoption of EVAR-first approach
Overall survival improved from 71% to 80% after a group of community practice surgeons started using an endovascular-first approach to ruptured abdominal aortic aneurysm...
The top 10 most popular Vascular Specialist stories in September
Five-year data from the ACST-2 trial comparing carotid endarterectomy and carotid artery stenting, a report from the Crawford Forum at the 2021 Vascular Annual...
Three-year VIVO results back ‘continued safety and effectiveness’ of Zilver Vena venous stent
Three-year results of the VIVO clinical study support the continued safety and effectiveness of the Zilver Vena venous stent (Cook Medical) in the treatment of symptomatic...
Vascular Specialist–October 2021
In this issue:
"Not all cuts disappear": We take a look at the threat posed to vascular surgery—and the office-based lab (OBL) setting in...
SVS task force continues fight to stop cuts
The Society for Vascular Surgery (SVS) Medicare Cuts Task Force is continuing its work to stop the proposed cuts in physician reimbursement from going...
Registry data show greater clot chronicity on post-procedure inspection than initially predicted
Nearly half of patients deemed pre-procedurally to be suffering an acute case of deep vein thrombosis (DVT) turned out to have a “much more”...
PROMISE I 24-month results ‘validate the benefits of the LimFlow system’
LimFlow has announced 24-month results from the PROMISE I study of the LimFlow percutaneous deep vein arterialization system, confirming “excellent and sustained outcomes” for...
‘TCAR yields high technical success with an extraordinarily low stroke and death rate at...
Outcomes in a cohort of patients who consented to one year of follow-up after transcarotid revascularization (TCAR) treatment for carotid stenosis in the ROADSTER...
Physicians, industry urged to tackle multifactorial stroke risk following thoracic endovascular procedures
As evidence builds on the importance of reducing the risk of stroke by removing residual air prior to thoracic endovascular aortic repair (TEVAR) procedures,...
One-year results show ‘superior’ primary patency rate for Eluvia DES compared to bare metal...
One-year results presented at Vascular Interventional Advances (VIVA) 2021 in Las Vegas (Oct. 5–7) from the EMINENT trial demonstrated the superiority of the Eluvia...
IN.PACT AV DCB sustained ‘superior’ effectiveness in subgroups with high reintervention rates out to...
Several subgroups of patients treated with the IN.PACT AV drug-coated balloon (DCB) for arteriovenous fistulas (AVFs) demonstrated a “statistically significant” higher rate of target...
VIVA 2021: IVL ‘consistently’ treats real-world calcium in multiple peripheral vessel beds
An interim analysis from the DISRUPT PAD III observational study showed that intravascular lithotripsy (IVL) performs “consistently well” across challenging peripheral vessels, lesions and...
Vascular surgeons found to ask twice as many closed- versus open-ended questions in patient...
Patients reported they mostly felt their provider was adequate in terms of engaging in shared decision-making during asymptomatic vascular consults, according to a qualitative...
Study detects no difference in adverse outcomes from balloon dilatation strategy used during TCAR
Avoiding a strategy of post-stent balloon dilation during transcarotid artery revascularization (TCAR) may be unnecessary—a “contradistinction” to results shown in conventional transfemoral carotid artery...
Two-year Ranger DCB data demonstrate ‘sustained, high rate’ of device efficacy
Patients treated with Boston Scientific’s Ranger drug-coated balloon (DCB) sustained “improved primary patency” with fewer reinterventions than those treated with uncoated devices, two-year results...
VIVA 2021: IN.PACT Admiral DCB found to provide ‘high five-year freedom from clinically driven...
Real-world data drawn from the IN.PACT Global study looking at five-year freedom from clinically driven target lesion revascularization (TLR) among prespecified chronic total occlusion...
VIVA 2021: Consensus established for appropriate use of IVUS in peripheral interventions
A worldwide committee of 40 cross-specialty medical experts achieved what was hailed as the first-ever consensus for the appropriate use of intravascular ultrasound (IVUS)...
Cuts to Medicare: ‘As vascular disease complexity increases, reimbursement for complex care decreases’
Outgoing Midwestern Vascular Surgical Society (MVSS) President Kellie Brown, MD, has seen fundamental changes to the way vascular surgery is practiced during her 20...
AI and transforming vascular surgery
The 2021 Vascular Annual Meeting (VAM) Roy Greenberg Distinguished Lecture saw delegates hear about the potential for artificial intelligence (AI) to transform vascular surgery....
Surgeons relate patient-reported outcomes experiences
Ashley K. Vavra, MD, and Christopher J. Smolock, MD, talk to Vascular Specialist about why they decided to collect patient-reported outcomes (PROs), how they...
VQI partners with Symmetric Health Solutions to improve device identification accuracy
The Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) has announced a partnership with Symmetric Health Solutions aimed at elevating the consistency and...
Spotlight: Vascular surgeons in the news
Daniel Clair, MD, has been named the inaugural chair of the newly formed Department of Vascular Surgery in the Section of Surgical Sciences at...
UCLA-SVS review course starts Oct. 1
There’s less than a month left to register for the Sixth Annual UCLA-SVS Symposium set to take place Oct. 1 to 3 at the...
Save the date for new PAD skills workshop
September is National PAD Awareness Month, and the Society for Vascular Surgery (SVS) will spend the month not only calling attention to causes and...
Endologix launches randomized study of Alto EVAR device
Endologix today announced that the first patient has been enrolled in the company’s JAGUAR study to compare outcomes for the company’s Alto abdominal stent...
What is taxonomy and how does it affect vascular surgeons?
Have you ever had a bill denied for services of your assistants and not known why? Have you received cryptic messages on an explanation...
SVS: A lesson in unity through diverse talent
Today’s emphasis on diversity is nearly inescapable, while examples of true unity seem scarcer. Is there really a way the two can co-exist or...
First patient enrolled in BIONETIC-I study of iliac artery treatment
Biotronik has announced the first patient enrollment in the BIONETIC-I study of the safety and efficacy of the Dynetic-35 cobalt chromium balloon-expandable stent system...
VAM 2021 structural changes prove hit with attendees
It was an epic return: nearly 700 abstracts presented in six plenaries and several other forums; six concurrent sessions; six SVS breakfast sessions; three...
EVS 2021: Vascular surgery as ‘an enabling service’ for the wider healthcare system
Vascular surgery is as important as anesthesia in providing a safe operating room (OR), Richard Powell, MD, the vascular section chief at Dartmouth-Hitchcock Medical...
‘Proceed cautiously in use of DCBs in CLTI patients with advanced WIfI stage’
The last several years have seen ongoing controversy and debate about the risks and benefits of paclitaxel-coated devices (PCDs) for patients with peripheral arterial...
PCBs: Panel of vascular surgeons review latest findings on paclitaxel-coated balloons
A recent meta-analysis by Konstantinos Katsanos, MD, of Patras University Hospital, Rion, Greece, and colleagues—“Risk of major amputation following application of paclitaxel-coated balloons ...
Survey on radiation safety in vascular trainees demonstrates a quarter received no feedback on...
A collaborative effort is needed to establish and adhere to best practice guidelines for radiation safety and exposure, Jasmine Bhinder, MD, a general surgery...
Key players behind first SVS AUC on claudication unpack details of development process
Vascular surgeons have a history of going the extra mile to do the right thing for their patients. So went the theme of one...
Corner Stitch: The art of surgery in the present moment
As a young surgeon-in-training, and a millennial, the concept of mindfulness and wellbeing perfuses my day-to-day life. Reminders of the importance of “being present”...
First-in-human study of Wrapsody endoprosthesis yields ‘very promising’ results
Merit Medical Systems has announced positive results from a prospective, observational, first-in-human study to evaluate the safety and effectiveness of Wrapsody—a self-expanding, cell-impermeable endoprosthesis...
CMS creates new billing code for central venous vascular access system
Bluegrass Vascular Technologies announced today that the Centers for Medicare & Medicaid Services (CMS) has finalized a new Healthcare Common Procedure Coding System (HCPCS)...
TCAR may be associated with favorable outcomes in restenotic carotid lesions, study suggests
Transcarotid artery revascularization (TCAR) may be associated with favorable in-hospital outcomes for the treatment of restenotic carotid lesions after carotid endarterectomy (CEA), suggests a...
Terumo Aortic announces first commercial implants of RelayPro in US
Terumo Aortic today announced the first commercial implants in the U.S. of its RelayPro thoracic stent-graft system. This follows the recent approval by the...
Vascular Connections–September 2021 (Review Edition)
In this VAM review issue:
Outgoing President Ronald L. Dalman, MD, deals with the challenges of COVID-19 and the future direction of the Society...
Vascular Specialist–September 2021
In this issue:
We hear from five vascular surgeons on the latest signal around paclitaxel-coated balloon (PCB) use in patients with peripheral arterial disease...
SVS branding campaign wins communications award
The Society for Vascular Surgery (SVS) branding campaign has received a “Profiles of Excellence Award” from the American Association of Medical Society Executives for...
Significant reintervention after F-BEVAR ‘does not negatively impact survival’
Patients who underwent reinterventions after fenestrated and branched endovascular aneurysm repair (F-BEVAR) had improved long-term survival over those who did not undergo a secondary...
‘Do we need to do a better job of making devices that fit female...
It was a burning question posed from the conference floor, and it led to some approving social media nods in its aftermath: Does the...
The top 10 most popular Vascular Specialist stories in August
Our recent editorial on the status of the interview, one of the Presidential Addresses from the Vascular Annual Meeting (VAM), a slew of new...
New imaging technique has potential to identify patients at high risk of aortic degeneration,...
Four-dimensional (4D) flow magnetic resonance imaging (MRI) has the potential to identify patients with a higher risk of severe complications from aortic degeneration, according...
MVSS 2021: Midwestern Vascular unveils 2021–22 leadership changes
The Midwestern Vascular Surgical Society (MVSS) announced a new slate of officers at its 2021 annual meeting held in Chicago from Sept. 9–11. Raghu...
European launch: Medtronic receives CE mark for 200mm and 250mm IN.PACT Admiral DCBs
Medtronic has announced the European launch of the 200mm and 250mm IN.PACT Admiral drug-coated balloons (DCBs) following CE mark approval. The product is intended to treat long...
PAD: R3 Vascular reports ‘successful initiation’ of first-in-human study of bioresorbable sirolimus-eluting scaffold
Medical device developer R3 Vascular has reported the "successful initiation" of a first-in-human clinical study evaluating the technical and clinical performance of its Magnitude...
Thirty-year experience indicates SMA aneurysms are ‘relatively stable’
Based on 30 years of experience, researchers have concluded that aneurysms of the superior mesenteric artery (SMA) are “relatively stable” and that those <20mm...
Physicians draw attention to Medicare cuts as PAD Awareness Month kicks off
A coalition of physicians and other interested parties focused on peripheral arterial disease (PAD) has called on Congress and the Centers for Medicare and...
‘Tremendous advances in imaging possibilities’ signal further innovation, says leading vascular chief
It was a complex repair in the thoracoabdominal region of the aorta around 10 years ago, and Matthew Eagleton, MD, and his surgical team...
Five-year ACST-2 results: Carotid artery surgery and stenting have similar long-term effects on stroke
Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke in asymptomatic patients with severe carotid artery stenosis. That is the finding of...
Spotlight: Melina Kibbe, James Black and Firas Mussa
Melina Kibbe, MD, has been named the 17th dean of the University of Virginia School of Medicine and chief of the Health Affairs Office...
SVS Foundation Board, Development Committee approved
The SVS Executive Board has approved the 2021–22 SVS Foundation Board appointments, as recommended by the Foundation Board.
Continuing for an additional one-year term...
Females were 30% less likely to undergo surgery for PAD, national database study finds
A review of more than 1 million patients receiving vascular surgery over a 16-year period identified significant sex-related disparities in the treatment of abdominal...
USPSTF expands screening recommendation for prediabetes, type-2 diabetes to adults aged 35-plus
The United States Preventive Services Task Force (USPSTF) has issued an updated recommendation statement suggesting clinicians screen for prediabetes and type-2 diabetes in overweight...
SVS billing and coding workshop to take place Dec. 5 and 6
While a surgeon’s expertise is key to patient outcomes, coding and documenting the procedures are key to the surgeon’s payment and reimbursement.
And, when...
SVS membership, CME-MOC deadlines fall in September
The third deadline of 2021 to apply for Society for Vascular Surgery (SVS) membership is Sept. 1. Be a part of the premiere organization...
VAM discussion on latest paclitaxel meta-analysis yields mix of caution, skepticism
A Vascular Annual Meeting (VAM) sponsored session on paclitaxel safety drew a mix of skeptical and cautious responses to the latest meta-analysis from interventional...
Amputation rates higher for people with PAD who are poor or Black
Poverty and Black race were associated with higher rates of lower-leg amputation among people with peripheral arterial disease (PAD) who live in metropolitan areas, according to new...
Registration for UCLA-SVS vascular review course open
The Sixth Annual University of California Los Angeles (UCLA)-Society for Vascular Surgery (SVS) Symposium returns as a live course for 2021 from Oct. 1...
First patient enrolled in AAA-SHAPE Netherlands study
Shape Memory Medical has announced the initiation of AAA-SHAPE Netherlands, the company’s prospective, multicenter early feasibility study of the Impede-FX RapidFill device when used...
Vascular Quality Initiative launches ‘My PAD’ pilot
The Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) has created “My PAD,” a pilot program for collecting patient-reported outcomes (PROs) from patients...
SVS publishes diversity, equity and inclusion supplement—exploring route forward
On the heels of a worldwide pandemic that has helped expose deep disparities in healthcare, the Society for Vascular Surgery (SVS) published a response—and...
FDA approves expanded PAD indication for rivaroxaban plus aspirin
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Food and Drug Administration (FDA) has approved an expanded peripheral arterial disease...
Caring for the veteran, training the surgeon: The role of the VA in vascular...
In May 1945, President Harry Truman appointed Gen. Omar Bradley to lead what is now the United States Department of Veteran Affairs, with Paul...
